Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3009991	li-ace	— (—)	1367	1421	100.00%	Distribution not available
3009991	li-ace	u/l (u/l)	1118	1201	2.83%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other demyelinating diseases of the central nervous system

253

38.05

307.65

1.1

1.00

1.04

u/l

0.33

109

Other degenerative diseases of the nervous system

516

105

38.63

307.65

1.1

1.0

0.99

1.20

u/l

1.92

209

Neurological diseases

789

404

9.94

307.65

1.1

1.0

1.03

1.11

u/l

1.22

337

188

Symptoms and signs involving the nervous and musculoskeletal systems

748

968

7.90

307.65

1.1

1.04

1.10

u/l

0.66

366

417

Demyelinating diseases of the central nervous system

461

179

29.33

307.65

1.1

0.99

1.04

u/l

0.86

182

Other symptoms and signs involving the nervous and musculoskeletal systems

578

717

8.26

307.65

1.1

1.04

1.06

u/l

0.28

280

303

MS-disease / Multiple Sclerosis

375

151

28.15

307.65

1.0

1.1

0.95

1.03

u/l

1.76

131

Disturbances of skin sensation

458

575

8.22

307.65

1.1

1.04

1.07

u/l

0.44

193

258

Neurological diseases, wide definition

359

21.50

288.74

1.1

1.0

1.00

0.97

u/l

0.50

154

Abnormal findings on diagnostic imaging of central nervous system

189

23.48

256.03

1.1

1.02

1.07

u/l

0.43

Disorders of optic nerve and visual pathways

239

191

13.27

247.06

1.2

1.0

1.07

1.11

u/l

0.26

101

Visual disturbances and blindness

494

933

5.38

246.52

1.1

1.05

1.06

u/l

0.09

226

414

Visual disturbances

477

883

5.49

243.47

1.1

1.05

1.06

u/l

0.26

218

390

Polyneuropathies and other disorders of the peripheral nervous system

279

295

9.73

237.44

1.1

1.03

1.11

u/l

1.15

146

147

Postprocedural disorders of nervous system

207

159

13.88

219.36

1.1

1.0

1.02

1.05

u/l

0.20

Headache

576

1089

4.47

218.49

1.1

1.06

1.03

u/l

0.47

260

484

Symptoms and signs involving the skin and subcutaneous tissue

590

1414

4.20

218.41

1.1

1.04

1.09

u/l

0.79

248

652

Other and unspecified polyneuropathies, also in other diseases

247

250

10.17

217.12

1.1

1.04

1.11

u/l

0.99

129

135

Autoimmune diseases related-to ILD

684

1661

3.66

201.69

1.1

1.01

1.09

u/l

1.58

271

786

Other neurological diseases

543

1003

4.40

199.42

1.1

1.08

1.09

u/l

0.10

245

476

Autoimmune diseases excluding thyroid diseases

775

1266

3.42

178.52

1.1

1.02

1.08

u/l

1.03

336

564

Autoimmune diseases excluding thyroid diseases, strict definition

750

1233

3.42

172.43

1.1

1.03

1.07

u/l

0.60

326

546

Optic neuritis

141

15.62

158.65

1.1

1.0

0.96

1.04

u/l

0.91

ILD medications: immunosuppressive drugs

478

1248

3.71

147.69

1.2

1.0

1.04

1.10

u/l

0.77

215

551

General symptoms and signs

749

1212

3.12

144.47

1.1

1.10

1.04

u/l

0.57

336

546

Symptoms and signs involving cognition, perception, emotional state and behaviour

663

1495

3.13

144.35

1.1

1.07

1.08

u/l

0.11

277

695

Diplopia

178

202

9.08

143.73

1.1

1.02

1.14

u/l

1.57

103

Concussion

229

282

7.07

142.79

1.1

1.0

1.07

1.09

u/l

0.14

131

Encephalitis

105

21.04

136.19

1.5

1.0

1.07

1.08

u/l

0.03

ILD medications

769

1477

2.88

134.38

1.1

1.03

1.08

u/l

0.84

349

651

Intracranial trauma

251

294

6.41

134.34

1.1

1.0

1.06

1.09

u/l

0.22

106

136

Inflammatory diseases of the central nervous system

155

162

9.98

133.52

1.3

1.1

1.12

1.11

u/l

0.02

Other encephalitis

100

22.10

132.41

1.5

1.0

1.07

1.08

u/l

0.05

Autoimmune diseases

720

1273

2.91

124.95

1.1

1.05

1.08

u/l

0.37

315

567

Used for control exclusion in common control thyroid runs

679

1176

2.94

120.20

1.1

1.02

1.08

u/l

0.78

302

516

Sarcoidosis

174

241

7.42

118.98

1.4

1.0

1.22

1.11

u/l

0.76

124

Subjective visual disturbances

233

435

5.45

118.18

1.1

1.08

u/l

0.03

109

196

Other disorders of optic [2nd] nerve and visual pathways

125

121

10.84

113.92

1.2

1.0

1.14

1.13

u/l

0.03

Other symptoms and signs involving cognitive functions and awareness

280

581

4.57

113.76

1.1

1.12

1.05

u/l

0.68

115

280

Abnormalities of gait and mobility

126

124

10.42

113.01

1.1

1.08

1.17

u/l

0.40

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

381

1016

3.50

107.47

1.1

1.05

1.11

u/l

0.70

197

468

Nerve, nerve root and plexus disorders

651

1541

2.67

104.00

1.1

1.04

1.09

u/l

0.74

311

685

Certain disorders involving the immune mechanism

197

362

5.55

101.80

1.3

1.0

1.20

1.09

u/l

1.03

103

172

Benign intracranial hypertension

38.75

101.17

1.2

1.1

1.13

1.05

u/l

—

Papilloedema, unspecified

18.74

98.32

1.3

1.0

1.10

1.09

u/l

0.05

Dizziness and giddiness

439

1166

3.08

97.21

1.1

1.04

1.09

u/l

0.61

197

539

Episodal and paroxysmal disorders

684

1375

2.56

94.91

1.1

1.04

1.05

u/l

0.22

290

627

Malaise and fatigue

289

617

3.93

93.54

1.1

1.05

1.06

u/l

0.16

126

277

Diagnoses used for exclusion with ILD

203

416

4.95

92.60

1.3

1.1

1.20

1.08

u/l

1.13

108

190

Use of teriflunomide

31.18

90.54

1.0

1.1

0.97

1.20

u/l

—

Diseases of the eye and adnexa

553

991

2.81

90.31

1.1

1.0

1.01

1.11

u/l

1.57

244

438

Other soft tissue disorders, not elsewhere classified

585

1398

2.60

88.52

1.1

1.05

1.08

u/l

0.33

257

627

Migraine

372

1023

3.12

85.33

1.1

1.05

u/l

0.05

171

438

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

225

216

5.26

82.78

1.1

1.07

1.04

u/l

0.25

114

Bell's palsy

131

201

6.67

81.51

1.1

1.10

1.14

u/l

0.18

103

ILD medications: prednisolone, methylprednisolone, prednisone

618

1440

2.44

80.06

1.1

1.05

1.08

u/l

0.40

299

638

Cerebral cysts

106

9.42

79.41

1.2

1.0

1.07

1.06

u/l

0.03

Paralytic strabismus

105

9.34

78.42

1.1

1.08

1.15

u/l

0.38

Other dorsopathies, not elsewhere classified

608

1322

2.44

77.25

1.1

1.01

1.07

u/l

1.03

265

582

Dorsalgia

589

1314

2.44

75.55

1.1

1.02

1.07

u/l

0.82

255

580

Cerebral palsy and other paralytic syndromes

125

209

6.11

71.49

1.1

1.14

1.11

u/l

0.15

105

Disorders of ocular muscles, binocular movement, accommodation and refraction

332

1139

2.92

70.38

1.1

1.05

u/l

0.01

145

489

Other headache syndromes

277

869

3.21

69.74

1.1

1.10

1.05

u/l

0.54

112

377

Pain in joint

335

729

3.06

69.56

1.1

1.07

1.08

u/l

0.12

156

340

L04AX Other immunosuppressants

352

1275

2.78

68.59

1.2

1.1

1.04

1.08

u/l

0.34

169

567

Second line medication for Crohn's disease

357

1317

2.73

67.16

1.2

1.1

1.05

1.08

u/l

0.28

172

590

Cerebrovascular diseases (FINNGEN)

237

467

3.67

66.29

1.1

1.12

1.13

u/l

0.05

108

227

Pain in limb

452

1318

2.49

65.88

1.1

1.06

1.08

u/l

0.25

190

597

Care involving use of rehabilitation procedures

366

1319

2.65

64.37

1.1

1.17

1.06

u/l

0.51

158

612

Dorsopathies

587

1331

2.26

62.84

1.1

1.03

1.07

u/l

0.54

256

584

Low back pain

408

1245

2.54

62.67

1.1

1.05

1.07

u/l

0.20

164

553

L04AA Selective immunosuppressants

179

457

3.97

61.86

1.1

1.05

1.08

u/l

0.25

211

Migraine with aura

192

520

3.73

60.93

1.1

0.99

1.07

u/l

1.35

221

Oral corticosteroids

584

1621

2.19

60.87

1.2

1.0

1.08

1.06

u/l

0.18

282

718

First line medication for Crohn's disease

618

1580

2.14

59.43

1.1

1.05

u/l

0.02

284

686

Medical observation and evaluation for suspected diseases and conditions

376

707

2.74

59.38

1.1

1.04

1.12

u/l

0.80

169

335

Anxiety disorders, excluding more controls

481

1383

2.32

58.62

1.1

1.04

1.08

u/l

0.60

216

639

Small fibre neuropathy

15.24

58.30

1.1

1.0

1.10

1.13

u/l

0.09

Inflammatory bowel disease treatment related agents

626

1699

2.10

58.04

1.1

1.0

1.08

1.06

u/l

0.22

294

744

Condition for Implicit Sepsis (Organ dysfunction codes)

432

1322

2.39

57.47

1.1

1.05

1.08

u/l

0.37

184

619

Strabismus

204

599

3.44

57.16

1.1

1.07

1.06

u/l

0.08

269

Disorders of thyroid, IBD co-morbidities

10.38

57.16

1.1

1.0

1.06

0.97

u/l

0.66

Abnormal involuntary movements

104

184

5.74

56.10

1.0

1.1

0.99

1.13

u/l

1.92

Infections, IBD-co-morbidities

13.58

55.77

1.1

1.0

1.03

0.97

u/l

0.40

Guillain-Barre syndrome

18.70

55.47

1.1

1.0

1.03

1.16

u/l

0.50

Anxiety disorders

521

1708

2.17

55.45

1.1

1.03

1.08

u/l

0.69

229

766

Cerebrovascular diseases

335

909

2.65

55.36

1.1

1.12

1.11

u/l

0.07

148

448

Pain, not elsewhere classified

165

433

3.84

54.80

1.0

1.1

1.25

1.07

u/l

0.33

187

Neurotic, stress-related and somatoform disorders

516

1704

2.16

54.40

1.1

1.03

1.08

u/l

0.72

226

763

Other special examinations and investigations of persons without complaint or reported diagnosis

367

707

2.64

54.06

1.1

1.02

1.12

u/l

1.21

149

335

General examination and investigation of persons without complaint and reported diagnosis

348

707

2.63

51.90

1.1

1.02

1.12

u/l

1.12

148

335

Lower back pain or/and sciatica

539

1820

2.06

50.13

1.1

1.04

1.07

u/l

0.52

235

829

Epilepsy

176

514

3.44

49.63

1.1

1.07

u/l

0.02

235

Myalgia

161

450

3.62

48.88

1.1

1.05

1.09

u/l

0.24

204

STROKE

308

825

2.61

48.72

1.1

1.11

1.12

u/l

0.13

140

400

Systemic atrophies primarily affecting the central nervous system

9.99

48.55

1.1

1.03

1.11

u/l

0.53

Depression

521

1774

2.03

46.43

1.1

1.03

1.08

u/l

0.84

211

822

Other acute disseminated demyelination

17.26

45.78

1.1

0.99

1.09

u/l

0.36

Pain (limb, back, neck, head abdominally)

362

747

2.44

45.61

1.1

1.03

1.08

u/l

1.06

160

345

Other intervertebral disc disorders

407

1123

2.23

44.60

1.1

1.07

1.08

u/l

0.04

189

503

Soft tissue disorders

549

1425

2.01

44.34

1.1

1.01

1.08

u/l

1.54

235

634

Mood disorders, excluding more controls

486

1440

2.06

43.87

1.1

1.04

1.08

u/l

0.64

195

664

Fever of other and unknown origin

251

890

2.63

43.46

1.2

1.1

1.10

1.05

u/l

0.62

132

398

Other antidepressants

526

1362

2.02

43.35

1.1

1.03

1.09

u/l

1.04

225

628

Neuromuscular dysfunction of bladder

152

5.56

43.28

1.2

1.1

1.03

1.09

u/l

0.52

Sciatica+with lumbago

256

947

2.58

42.94

1.1

1.02

1.09

u/l

1.06

119

428

Systemic connective tissue disorders

187

638

2.95

41.01

1.1

1.13

1.08

u/l

0.38

290

Mood [affective] disorders

530

1809

1.93

40.91

1.1

1.03

1.08

u/l

0.84

211

838

Stroke, excluding SAH

239

666

2.68

40.82

1.1

1.10

1.11

u/l

0.06

106

331

Mood disorders

529

1809

1.93

40.44

1.1

1.03

1.08

u/l

0.84

211

838

Spirochaetal infections, other/unspecified

152

5.37

40.13

1.1

1.14

1.16

u/l

0.07

Enlarged lymph nodes

101

235

4.34

39.65

1.1

1.04

1.07

u/l

0.17

102

Any reimbursement code in KELA

374

845

2.23

38.81

1.1

1.03

1.05

u/l

0.21

160

379

Other disorders of lacrimal gland

190

675

2.84

38.74

1.1

1.02

1.08

u/l

1.15

298

Migraine without aura

150

468

3.24

38.45

1.1

1.07

1.06

u/l

0.04

194

Implicit Sepsis

328

1147

2.23

38.37

1.1

1.03

1.08

u/l

0.80

140

540

Recurrent or chronic depression

248

705

2.56

38.34

1.1

1.07

1.12

u/l

0.28

315

Convulsions, not elsewhere classified

135

389

3.45

38.33

1.1

1.02

1.03

u/l

0.08

173

Sixth [abducent] nerve palsy

9.19

38.27

1.1

1.0

1.09

1.12

u/l

0.11

Lumbar disc prolapse

304

1058

2.29

38.10

1.1

1.12

1.08

u/l

0.28

132

474

Ischaemic Stroke, excluding all haemorrhages

219

617

2.70

38.08

1.1

1.10

1.07

u/l

0.33

307

Stroke, including SAH

248

728

2.53

37.91

1.1

1.10

1.11

u/l

0.01

111

368

Other lack of coordination

14.36

36.78

1.1

1.00

1.01

u/l

0.08

Tramadol

391

1213

2.08

36.76

1.1

1.09

1.08

u/l

0.07

169

541

Dysphagia

127

368

3.48

36.61

1.1

1.03

1.08

u/l

0.62

163

Anxiety (asthma-related co-morbidities)

359

1350

2.11

36.49

1.1

1.02

1.09

u/l

0.99

153

605

Other disorders of eye and adnexa

109

288

3.84

36.11

1.1

1.02

1.11

u/l

1.11

130

Opioids

519

1455

1.88

34.96

1.1

1.02

1.07

u/l

0.73

215

645

All anxiety disorders

363

1428

2.06

34.77

1.1

1.02

1.07

u/l

0.68

153

616

Disorders of lacrimal system

209

824

2.55

34.75

1.1

1.03

1.08

u/l

0.72

358

Examination and observation for other reasons

269

697

2.36

33.61

1.1

1.05

1.12

u/l

0.55

331

Codeine

486

1424

1.88

33.31

1.1

1.04

1.07

u/l

0.47

206

634

Persons encountering health services for specific procedures and health care

521

1780

1.82

33.05

1.1

1.15

1.05

u/l

0.69

227

807

Depression or dysthymia

334

875

2.14

32.80

1.1

1.03

1.10

u/l

0.89

138

410

Chorioretinal inflammation

9.00

32.07

1.3

1.1

1.17

1.09

u/l

0.29

Migraine with aura and triptan purchases

125

395

3.20

31.51

1.0

1.1

0.99

1.04

u/l

0.59

157

Other and unspecified visual disturbances

166

4.59

31.51

1.0

1.1

0.98

1.15

u/l

2.01

Non-invasive ventilation

130

391

3.15

31.50

1.1

1.02

1.07

u/l

0.56

195

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

443

1717

1.86

30.93

1.2

1.1

1.21

1.04

u/l

1.46

216

765

Persons encountering health services for examination and investigation

306

707

2.18

30.30

1.1

1.04

1.12

u/l

0.75

132

335

Pain in throat and chest

418

1351

1.90

30.21

1.1

1.07

1.09

u/l

0.20

192

608

Spondylopathies

324

950

2.08

30.13

1.1

1.13

1.09

u/l

0.36

145

442

Psychiatric diseases

514

1435

1.80

29.99

1.1

1.04

1.08

u/l

0.53

222

668

Spondylosis

207

736

2.42

29.98

1.1

1.08

1.12

u/l

0.27

351

Any gastric operation

420

1112

1.90

29.09

1.1

1.05

1.06

u/l

0.03

190

477

GASTRO-related operations

420

1112

1.90

29.09

1.1

1.05

1.06

u/l

0.03

190

477

Ocular pain

166

4.41

28.79

1.1

1.04

1.14

u/l

0.78

Other anxiety disorders

274

1166

2.10

28.24

1.1

1.04

1.05

u/l

0.03

117

506

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

121

5.04

28.19

1.1

1.83

1.07

u/l

0.96

Other general symptoms and signs

6.53

28.17

1.1

1.0

1.03

1.18

u/l

0.70

Cardiovascular diseases

384

1092

1.92

28.11

1.1

1.05

1.04

u/l

0.03

176

470

Radiculopathy

199

4.00

28.01

1.1

1.01

1.11

u/l

1.18

Other/unspecified dorsalgia

171

678

2.52

27.88

1.1

1.03

1.12

u/l

0.76

289

Extrapyramidal and movement disorders

153

578

2.66

27.86

1.1

1.01

1.07

u/l

1.12

273

Any mental disorder

509

1453

1.76

27.64

1.1

1.03

1.08

u/l

0.78

225

672

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

5.65

27.62

1.1

1.37

1.08

u/l

1.30

Depression medications

204

411

2.51

27.58

1.1

0.99

u/l

0.05

168

Syncope and collapse

168

585

2.55

27.50

1.0

1.1

1.07

1.05

u/l

0.15

263

Fibromyalgia

168

4.29

27.45

1.1

1.00

1.10

u/l

0.93

Symptoms and signs involving the circulatory and respiratory systems

514

1479

1.75

27.30

1.1

1.04

1.08

u/l

0.46

225

656

Other systemic involvement of connective tissue (FG)

130

453

2.87

27.26

1.1

1.15

1.06

u/l

0.57

201

Hypothyroidism, strict autoimmune

298

968

2.04

27.19

1.1

1.11

1.07

u/l

0.36

138

421

Other specific joint derangements/joint disorders

390

1416

1.85

26.86

1.1

1.06

1.07

u/l

0.11

184

622

Third [oculomotor] nerve palsy

10.81

26.41

1.0

1.01

1.15

u/l

0.62

Disorders of vestibular function (Vertigo)

195

841

2.31

26.32

1.1

1.11

1.06

u/l

0.42

401

Focal epilepsy

117

397

2.97

26.12

1.1

1.04

1.08

u/l

0.26

181

Focal epilepsy, mode (most common among epilepsy diagnosis)

108

351

3.10

26.01

1.1

1.05

1.08

u/l

0.24

165

Cervicalgia

101

318

3.20

25.65

1.1

1.09

1.08

u/l

0.03

144

Focal epilepsy, strict definition

108

355

3.07

25.51

1.1

1.05

1.08

u/l

0.23

168

Asthma, excluding more controls

364

1029

1.89

25.33

1.1

1.03

1.08

u/l

0.49

163

452

Viral infections of the central nervous system

166

4.17

25.29

1.3

1.1

1.58

1.11

u/l

0.52

Asthma

366

1045

1.88

25.23

1.1

1.0

1.03

1.08

u/l

0.55

163

458

Diseases of the musculoskeletal system and connective tissue

287

699

2.07

25.11

1.1

1.04

1.09

u/l

0.33

133

293

Asthma (mode)

360

1052

1.89

25.01

1.1

1.03

1.08

u/l

0.53

159

460

Other systemic involvement of connective tissue

133

498

2.69

24.73

1.1

1.14

1.08

u/l

0.33

225

COPD differential diagnosis

387

1053

1.85

24.65

1.1

1.03

1.08

u/l

0.49

175

461

Other meningitis

9.79

24.57

1.2

1.1

1.27

1.11

u/l

0.55

Hemiplegia

5.43

24.51

1.1

0.97

1.06

u/l

0.70

Abnormalities of breathing

432

1464

1.76

24.51

1.1

0.99

1.08

u/l

2.00

190

651

ILD differential diagnosis

386

1052

1.84

24.46

1.1

1.03

1.08

u/l

0.50

175

460

Follow-up examination after treatment for conditions other than malignant neoplasms

196

557

2.31

24.21

1.0

1.1

0.95

1.08

u/l

3.66

257

Factors influencing health status and contact with health services

148

269

2.77

24.16

1.1

1.09

u/l

0.03

121

Disorders of eyelid, lacrimal system and orbit

357

1543

1.82

24.07

1.1

1.04

1.09

u/l

0.74

173

688

Other necrotizing vasculopathies (FG)

5.58

23.69

1.2

1.1

1.06

1.14

u/l

0.47

Diseases of inner ear

214

989

2.13

23.53

1.1

1.10

1.06

u/l

0.41

465

Diseases of the myoneural junction and muscle

193

3.77

23.51

1.1

1.06

1.15

u/l

0.32

102

Cervical disc disorders

146

587

2.50

23.48

1.1

1.13

1.15

u/l

0.09

273

Oedema, not elsewhere classified

114

403

2.83

23.40

1.1

1.05

1.07

u/l

0.23

172

Excluding asthma or asthma-COPD overlap

383

1057

1.82

23.38

1.1

1.04

1.08

u/l

0.44

174

462

ILD medications: azathioprine

281

3.23

23.24

1.3

1.0

1.13

1.11

u/l

0.14

122

Other disorders of binocular movement

6.91

23.10

1.1

0.98

1.05

u/l

0.42

Other and unspecified nerve root and plexus disorders, also in other diseases

101

339

3.00

23.07

1.1

1.10

u/l

0.01

160

Hypothyroidism (congenital or acquired)

166

386

2.48

23.00

1.1

1.04

1.00

u/l

0.56

159

Codeine or tramadol medication

524

1773

1.64

22.83

1.1

1.06

1.07

u/l

0.20

228

799

Cardiovascular diseases (excluding rheumatic etc)

374

1204

1.80

22.82

1.1

1.05

1.06

u/l

0.03

176

531

Disorders of optic nerve, not elsewhere classified

9.64

22.76

1.1

1.0

1.18

1.12

u/l

0.07

Viral encephalitis, not elsewhere classified/unspecified

9.63

22.76

1.4

1.0

2.23

1.11

u/l

0.51

Symptoms and signs involving the digestive system and abdomen

451

1319

1.72

22.72

1.1

1.12

1.06

u/l

0.35

201

599

Malignant neoplasm of brain

6.71

22.65

1.1

1.27

1.14

u/l

0.37

Triptan medication for migraine, single purchase ok

397

1545

1.75

22.62

1.1

1.04

1.08

u/l

0.42

174

679

Migraine, single triptan purchase ok & required. ICD-code if available is included

397

1545

1.75

22.62

1.1

1.04

1.08

u/l

0.42

174

679

Visual field defects

125

4.46

22.43

1.1

1.26

1.20

u/l

0.15

Optic atrophy

10.36

22.17

1.1

1.0

1.46

1.10

u/l

—

Hard cardiovascular diseases

293

988

1.91

22.02

1.1

1.10

1.11

u/l

0.03

136

487

Meningitis

111

4.69

22.00

1.2

1.1

1.24

1.08

u/l

0.99

Hypothyroidism and >3 levothyroxin purchases

163

385

2.45

21.96

1.1

1.04

1.00

u/l

0.51

159

Hypothyroidism, levothyroxine purchases

163

385

2.45

21.96

1.1

1.04

1.00

u/l

0.51

159

Other extrapyramidal and movement disorders in other diseases

102

355

2.89

21.85

1.1

1.04

1.10

u/l

0.91

173

Other pulmonary diagnosis

376

1057

1.79

21.68

1.1

1.04

1.08

u/l

0.48

168

462

Use of glatiramer acetate

7.53

21.37

1.0

1.1

0.89

1.07

u/l

—

Other diseases of urinary system

453

1528

1.67

21.33

1.1

1.07

u/l

0.01

208

684

Other strabismus

127

500

2.55

21.31

1.1

1.05

1.07

u/l

0.10

226

Antihypertensive medication - note that there are other indications

360

1106

1.79

21.22

1.1

1.03

1.08

u/l

0.48

143

507

Speech disturbances, not elsewhere classified

131

4.25

21.15

1.1

1.10

1.16

u/l

0.27

Parasetamol

400

1181

1.73

20.95

1.1

1.00

1.08

u/l

1.39

178

524

Other diseases of spinal cord

6.77

20.93

1.1

1.0

1.14

0.99

u/l

1.04

Symptoms and signs involving speech and voice

147

627

2.36

20.85

1.0

1.1

1.03

1.07

u/l

0.57

282

Somatoform disorder

351

2.85

20.55

1.1

1.05

1.09

u/l

0.26

158

Other reaction to severe stress, and adjustment disorders

205

1007

2.05

20.47

1.1

1.01

1.05

u/l

0.67

435

Monoplegia

10.40

20.39

1.2

1.0

1.53

1.14

u/l

—

Symptoms and signs involving the urinary system

297

1259

1.83

20.38

1.1

1.10

1.09

u/l

0.12

126

591

Diseases of the ear and mastoid process

543

1736

1.59

20.32

1.1

1.06

1.07

u/l

0.19

252

770

Migraine without aura and triptan purchases

113

432

2.64

20.31

1.1

1.08

1.04

u/l

0.19

171

Other disorders of urethra and urinary system

298

1227

1.83

20.22

1.1

1.07

1.05

u/l

0.28

140

538

Use of dimethyl fumarate

11.16

20.21

1.0

1.1

0.90

1.08

u/l

—

Paraplegia, diplegia of upper limbs

8.18

20.12

1.2

1.1

1.39

1.11

u/l

0.74

Primary_lymphoid and hematopoietic malignant neoplasms

348

2.80

19.67

1.3

1.1

1.21

1.04

u/l

1.35

154

Cervicobrachial syndrome

102

378

2.71

19.47

1.1

1.00

1.09

u/l

1.56

170

Primary_lymphoid and hematopoietic malignant neoplasms

354

2.76

19.08

1.3

1.1

1.21

1.06

u/l

1.11

163

Azathioprine

316

2.87

19.06

1.3

1.1

1.13

1.06

u/l

0.63

136

Disorders of refraction and accommodation

139

601

2.32

18.99

1.1

1.03

1.05

u/l

0.14

276

Heterophoria

170

3.64

18.92

1.0

1.1

1.02

1.12

u/l

0.65

Parkinson's disease, excluding more controls

6.67

18.86

1.1

1.0

0.99

1.31

u/l

1.11

Other necrotizing vasculopathies

113

4.31

18.78

1.2

1.1

1.07

1.20

u/l

0.90

Coxibs

140

307

2.44

18.39

1.1

1.08

1.11

u/l

0.18

116

Sleep disorders (combined)

418

1688

1.63

18.39

1.1

1.12

1.06

u/l

0.29

185

769

Sequelae of cerebrovascular disease

109

372

2.58

18.39

1.0

1.1

1.12

1.08

u/l

0.23

194

Abdominal and pelvic pain

429

1319

1.64

18.33

1.1

1.12

1.06

u/l

0.29

190

599

Asthma (only as main-diagnosis)

307

1045

1.78

18.30

1.1

1.0

0.99

1.08

u/l

1.44

135

458

Viral Sepsis

302

2.87

18.21

1.1

1.01

1.08

u/l

0.79

146

Asthma (only as main-diagnosis), excluding more controls

306

1029

1.78

18.17

1.1

0.99

1.08

u/l

1.30

134

452

Persons encountering health services in other circumstances, wide

512

1704

1.56

18.15

1.1

1.07

1.08

u/l

0.09

225

772

Malignant neoplasm of eye, brain and central nervous system

5.10

18.13

1.1

1.35

1.12

u/l

0.73

Anaemias

123

329

2.50

18.11

1.1

1.0

1.46

1.01

u/l

0.73

136

Implicit viral Sepsis

300

2.85

17.84

1.1

1.01

1.08

u/l

0.79

146

Transient ischemic attack

160

617

2.16

17.83

1.1

1.10

1.07

u/l

0.27

306

302

2.84

17.66

1.1

1.08

1.09

u/l

0.09

136

Trigeminal neuralgia

4.53

17.53

1.1

1.08

1.19

u/l

0.44

Other facial nerve disorders

5.99

17.51

1.0

1.33

1.09

u/l

0.33

Temporomandibular joint disorders

260

2.98

17.50

1.0

1.06

1.16

u/l

0.94

110

Certain infectious and parasitic diseases

447

1400

1.60

17.50

1.1

1.09

1.03

u/l

1.06

207

610

Neuralgia and neuritis, unspecified

4.88

17.33

1.1

1.18

1.19

u/l

0.03

Parkinson's disease, strict definition, excluding more controls

6.41

17.01

1.1

1.0

0.96

1.31

u/l

1.23

Selective serotonin reuptake inhibitors

416

1366

1.61

16.68

1.1

1.02

1.09

u/l

1.07

185

629

Other joint disorders

429

1440

1.59

16.55

1.1

1.03

1.07

u/l

0.51

191

629

Other spirochaetal diseases

115

490

2.36

16.48

1.1

1.11

1.08

u/l

0.15

231

Metabolic disorders

375

1435

1.63

16.41

1.1

1.04

1.09

u/l

0.64

170

647

Atypical facial pain

4.75

16.37

1.1

1.07

1.10

u/l

0.09

Persons encountering health services for other counselling and medical advice, not elsewhere classified

462

1700

1.55

16.34

1.1

1.08

u/l

0.01

208

771

Brachial plexus disorders

203

3.19

16.26

1.1

1.18

1.09

u/l

0.31

Lyme disease

113

485

2.34

15.95

1.1

1.11

1.08

u/l

0.19

228

Nausea and vomiting

108

449

2.38

15.71

1.1

1.18

1.06

u/l

0.78

197

Lesion of lateral popliteal nerve

4.44

15.46

1.1

0.96

1.15

u/l

2.01

Pain in thoracic spine

252

2.88

15.41

1.1

0.99

1.08

u/l

0.94

115

Benzodiazepine use

415

1905

1.55

15.40

1.1

1.05

1.07

u/l

0.25

167

884

Hypertensive diseases (excluding secondary)

263

869

1.76

15.29

1.1

1.07

1.08

u/l

0.07

106

390

Irritable bowel syndrome

135

636

2.13

15.22

1.1

1.07

1.08

u/l

0.05

286

Cystitis

352

1330

1.62

15.20

1.1

1.09

1.04

u/l

0.48

157

585

Polyuria

352

2.54

15.03

1.0

1.1

0.96

1.10

u/l

3.06

164

Endocrine, nutritional and metabolic diseases

397

1277

1.59

15.03

1.1

1.05

u/l

0.00

184

550

Benign neoplasm of meninges

148

3.48

14.94

1.1

1.03

1.06

u/l

0.23

Iridocyclitis in diseases classified elsewhere

7.31

14.91

1.4

1.0

1.10

1.13

u/l

0.07

Status epilepticus

6.00

14.81

1.1

1.0

1.00

1.12

u/l

0.58

Asthma, unspecified (mode)

207

894

1.84

14.76

1.1

1.0

1.01

1.10

u/l

0.98

382

Asthma, unspecified (mode), excluding more controls

206

880

1.84

14.73

1.1

1.0

1.01

1.09

u/l

0.92

377

Benign neoplasm: Cerebral meninges

140

3.54

14.71

1.1

1.03

1.07

u/l

0.35

Vocal cord dysfunction

203

2.99

14.70

1.0

1.1

0.98

1.05

u/l

0.63

103

Disorders of sclera, cornea, iris and ciliary body

227

1292

1.76

14.59

1.1

1.08

u/l

0.04

118

573

Other diseases of upper respiratory tract

449

1536

1.53

14.55

1.1

1.03

1.09

u/l

1.02

222

683

Myasthenia gravis

7.93

14.50

1.1

1.0

0.97

1.13

u/l

—

Dyspnoea

342

1645

1.60

14.47

1.1

1.02

1.09

u/l

1.34

159

744

Implicit bacterial Sepsis

117

484

2.22

14.46

1.1

1.05

1.06

u/l

0.05

238

Retention of urine

112

418

2.27

14.35

1.2

1.1

1.08

u/l

0.02

211

Shoulder lesions

286

1044

1.68

14.24

1.0

1.1

1.03

1.11

u/l

1.21

127

484

Myocarditis

4.53

14.24

1.2

1.1

1.08

1.01

u/l

0.24

Fasciculation

10.36

14.10

1.0

1.1

0.93

1.19

u/l

—

Rotator cuff syndrome

212

875

1.80

14.04

1.0

1.1

1.02

1.12

u/l

1.60

415

Other symptoms and signs involving the urinary system

165

3.24

13.93

1.1

1.00

1.16

u/l

1.69

Visual impairment including blindness (binocular or monocular)

4.04

13.80

1.2

1.0

1.07

1.23

u/l

0.90

Gastrointestinal diseases

305

924

1.66

13.79

1.1

1.05

1.09

u/l

0.34

132

414

Abnormal findings on diagnostic imaging of lung

140

675

2.03

13.79

1.2

1.1

1.11

1.07

u/l

0.30

320

Symptoms and signs concerning food and fluid intake

122

3.63

13.78

1.2

1.0

1.10

1.12

u/l

0.09

Other and unspecified dermatitis

207

1167

1.78

13.78

1.1

1.11

1.08

u/l

0.12

519

Sleep apnoea

348

1503

1.57

13.63

1.1

1.14

1.07

u/l

0.30

154

694

Enthesopathies of lower limb, excluding foot

376

2.41

13.56

1.1

1.07

1.10

u/l

0.13

165

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

189

3.04

13.48

1.3

1.1

1.26

1.07

u/l

0.88

Asthma, including avohilmo

486

1928

1.47

13.36

1.1

1.02

1.08

u/l

1.26

223

858

Other disorders of central nervous system

8.81

13.33

1.1

1.18

1.02

u/l

—

Finngen Rheumatological endpoints

432

1643

1.50

13.27

1.1

1.09

1.06

u/l

0.27

193

736

Other disorders of fluid, electrolyte and acid-base balance

407

2.31

13.24

1.1

1.03

1.08

u/l

0.33

195

Lesion of ulnar nerve

229

2.81

13.22

1.0

1.1

1.04

1.13

u/l

0.83

118

Panic disorder

371

2.39

13.04

1.1

1.01

1.06

u/l

0.43

161

Triptan medication for migraine, min. 3 purchases

288

1409

1.62

13.02

1.1

1.07

1.05

u/l

0.13

121

607

SLE (Finngen)

5.28

12.99

1.1

1.0

1.02

1.07

u/l

—

Alzheimer disease, excluding more controls

4.80

12.95

1.2

1.1

1.00

1.30

u/l

1.16

Diseases of the respiratory system

288

876

1.65

12.86

1.1

1.05

1.11

u/l

0.48

128

387

Provisional assignment of new diseases of uncertain etiology

198

1126

1.76

12.83

1.1

1.09

1.04

u/l

0.45

481

Hypothyreosis and Thyroxine purchase for inclusion criteria

377

1635

1.52

12.81

1.1

1.11

1.05

u/l

0.57

175

704

Chronic sinusitis

183

1017

1.80

12.81

1.1

1.01

1.09

u/l

1.16

440

Hypothyroidism, other/unspecified

367

1583

1.53

12.80

1.1

1.11

1.05

u/l

0.57

169

678

Disorders of choroid and retina

268

1189

1.64

12.78

1.1

1.07

1.10

u/l

0.31

120

569

Codes for special purposes

198

1128

1.76

12.76

1.1

1.09

1.04

u/l

0.45

481

Hypothyroidism, drug reimbursement

204

2.64

12.73

1.1

1.0

1.01

0.98

u/l

0.39

Dermatitis

234

1404

1.67

12.49

1.1

1.11

1.08

u/l

0.24

104

639

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

208

1183

1.73

12.48

1.1

1.00

1.09

u/l

1.51

527

Benign paroxysmal vertigo

103

474

2.18

12.42

1.1

1.11

1.08

u/l

0.16

231

Disorders of the thyroid gland

389

1694

1.50

12.39

1.1

1.11

1.06

u/l

0.62

179

735

Other and unspecified paralytic syndromes

7.96

12.35

1.0

1.20

1.09

u/l

—

Special screening examination for infectious and parasitic diseases

125

455

2.06

12.32

1.1

1.0

0.94

1.14

u/l

1.76

207

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

133

676

1.98

12.30

1.1

1.04

1.05

u/l

0.06

291

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

4.10

12.26

1.0

1.21

1.26

u/l

0.09

Asthma (diagnoses ohter than nonallergic)

346

1949

1.52

12.18

1.1

0.99

1.08

u/l

2.50

153

870

Cluster headache, strict

4.98

12.18

1.2

1.0

1.05

1.10

u/l

0.20

Benign neoplasm of meninges

169

3.04

12.13

1.1

1.03

1.14

u/l

0.86

Bacterial Sepsis

131

589

1.98

12.06

1.1

1.16

1.05

u/l

0.89

280

Spinal stenosis

134

531

1.98

12.02

1.1

1.12

1.14

u/l

0.09

274

Benign neoplasm: Cerebral meninges

160

3.09

11.96

1.1

1.02

1.13

u/l

0.77

Cough

150

770

1.87

11.84

1.1

1.08

1.07

u/l

0.12

336

Oxycodone

113

531

2.06

11.79

1.1

1.15

1.13

u/l

0.07

261

Nystagmus and other irregular eye movements

6.88

11.53

1.1

1.0

0.94

1.13

u/l

—

Covid-19 confirmed case

118

589

2.01

11.52

1.1

1.09

1.04

u/l

0.38

252

Other disorders of optic disc

7.32

11.49

1.2

1.0

0.97

1.09

u/l

—

Asthma, hospital admission 2, infections

225

1344

1.65

11.49

1.1

1.03

1.08

u/l

0.36

585

Asthma-related infections

225

1344

1.65

11.49

1.1

1.03

1.08

u/l

0.36

585

Bacterial infection, other or unspecified

169

852

1.79

11.48

1.1

1.08

u/l

0.03

390

Exclusions for E4_PCOS_BROAD

380

2.28

11.48

1.2

1.1

1.13

1.08

u/l

0.22

176

Abnormal findings on diagnostic imaging of other body structures

202

2.79

11.46

1.3

1.0

1.20

1.13

u/l

0.20

101

Intracranial injury

217

1263

1.66

11.40

1.1

1.06

1.08

u/l

0.14

574

Organic, including symptomatic, mental disorders

129

473

1.97

11.27

1.1

1.11

1.07

u/l

0.27

248

Postviral fatigue syndrome

9.14

11.20

1.2

1.0

0.87

1.03

u/l

—

Cluster headache, wide

4.62

11.20

1.2

1.0

1.05

1.08

u/l

0.15

Non-selective monoamine reuptake inhibitors

126

631

1.94

11.12

1.0

1.1

1.13

1.08

u/l

0.32

290

183

1054

1.73

11.10

1.1

1.02

1.04

u/l

0.23

444

Use of hypnotics and sedatives

425

1700

1.45

11.03

1.1

1.09

1.07

u/l

0.13

185

773

Alzheimer’s disease, wide definition, excluding more controls

4.77

11.02

1.2

1.1

1.01

1.30

u/l

1.07

Abnormalities of heart beat

133

697

1.90

10.98

1.1

0.98

1.05

u/l

1.99

294

Rheumatism, unspecified

224

2.65

10.95

1.1

1.10

1.13

u/l

0.10

109

Other external causes of accidental injury

361

1206

1.50

10.91

1.1

1.02

1.08

u/l

0.88

161

535

Cervicocranial syndrome

169

2.92

10.89

1.1

1.07

1.11

u/l

0.25

Hypermobility syndrome

143

3.12

10.88

1.0

1.1

1.05

u/l

0.02

Chronic lower respiratory diseases

495

1907

1.41

10.81

1.1

1.03

1.08

u/l

0.97

216

861

Retinal detachments and breaks

106

522

2.04

10.78

1.1

1.01

1.07

u/l

0.90

261

Accidents

360

1206

1.50

10.75

1.1

1.03

1.08

u/l

0.79

157

535

Iridocyclitis

477

2.09

10.69

1.2

1.1

1.09

1.07

u/l

0.10

213

Disorders of other endocrine glands

172

977

1.74

10.65

1.1

1.15

1.04

u/l

0.81

425

Ptosis of eyelid

161

2.94

10.59

1.2

1.0

0.99

1.14

u/l

1.93

Viral infections characterized by skin and mucous membrane lesions

164

938

1.75

10.51

1.2

1.1

1.10

1.09

u/l

0.04

428

Post-traumatic stress disorder

212

2.67

10.50

1.1

0.99

1.02

u/l

0.17

Arthropathies

410

1441

1.45

10.49

1.1

1.04

1.07

u/l

0.34

187

629

Fall on same level

477

1900

1.40

10.44

1.1

1.04

1.07

u/l

0.53

214

844

Functional dyspepsia

110

556

1.99

10.43

1.1

0.98

1.08

u/l

2.20

255

Other mental disorders due to brain damage and dysfunction and to physical disease

136

3.11

10.42

1.1

1.15

1.16

u/l

0.03

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

133

717

1.86

10.40

1.2

1.1

1.09

1.07

u/l

0.08

323

External causes of morbidity and mortality

302

986

1.54

10.20

1.1

1.05

1.07

u/l

0.21

133

429

Acute upper respiratory infections

405

1775

1.43

10.10

1.1

0.99

1.10

u/l

2.62

169

805

Temporomandibular joint disorders, including avohilmo

202

1242

1.63

9.89

1.1

1.04

1.03

u/l

0.04

517

Benign neoplasms

358

1387

1.46

9.83

1.1

1.13

1.03

u/l

0.49

156

587

Other and unspecified mononeuropathies, also in other diseases

4.75

9.79

1.1

1.0

1.01

1.16

u/l

1.06

Sleep apnoea, including avohilmo

360

1611

1.45

9.78

1.1

1.14

1.07

u/l

0.29

165

732

Carpal tunnel syndrome

195

1076

1.64

9.67

1.1

1.05

1.11

u/l

0.74

478

Obesity related asthma

128

699

1.84

9.65

1.1

1.00

1.06

u/l

1.19

312

Diseases of oesophagus, stomach and duodenum

413

1776

1.41

9.63

1.1

1.06

1.07

u/l

0.16

188

806

Cramp and spasm

3.45

9.61

1.0

1.1

0.99

1.07

u/l

0.49

Osteopathies and chondropathies

189

1093

1.64

9.55

1.1

1.07

1.09

u/l

0.18

494

Hypertension, essential

315

1208

1.49

9.52

1.1

1.09

1.10

u/l

0.01

137

571

Other arthritis (FG)

119

639

1.87

9.47

1.1

1.17

1.03

u/l

1.09

273

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

4.14

9.45

1.1

0.93

1.12

u/l

1.99

Falls/tendency to fall

464

1674

1.39

9.41

1.1

1.03

1.07

u/l

0.62

203

738

Other specified/unspecified necrotizing vasculopathies

6.70

9.40

1.1

1.0

1.16

1.15

u/l

—

Hypo-osmolality and hyponatraemia

206

2.58

9.37

1.1

1.0

1.02

1.13

u/l

0.84

103

Chronic diseases of tonsils and adenoids

330

1429

1.46

9.33

1.1

1.03

1.09

u/l

0.68

143

632

Autonomic disorders

5.77

9.31

1.1

1.0

1.10

1.02

u/l

—

Algoneurodystrophy

3.69

9.30

1.0

1.1

1.21

1.05

u/l

—

Progressive vascular leukoencephalopathy

7.08

9.30

1.1

0.90

1.24

u/l

—

Non-allergic asthma (mode)

302

2.27

9.29

1.0

0.98

1.07

u/l

1.53

134

Acute sinusitis

229

1374

1.56

9.23

1.1

1.01

1.09

u/l

1.02

612

Acetic acid derivatives and related substances

114

303

1.97

9.20

1.1

1.06

1.11

u/l

0.27

115

Other enthesopathies

108

568

1.91

9.17

1.0

1.1

1.07

1.14

u/l

0.48

256

Pure hypercholesterolaemia

217

915

1.59

9.17

1.1

1.14

1.13

u/l

0.10

113

437

Disorders of synovium and tendon

194

1082

1.62

9.17

1.1

1.00

1.11

u/l

1.82

485

Other and unspecified degenerative diseases of nervous system

6.02

9.15

1.2

1.0

1.05

1.13

u/l

—

Zoster [herpes zoster]

277

2.32

9.07

1.3

1.1

1.14

1.11

u/l

0.07

136

Gastro-oesophageal reflux disease

241

1393

1.54

9.07

1.1

1.07

1.09

u/l

0.15

114

641

Dissociative [conversion] disorders

3.38

9.05

1.0

1.1

1.01

1.06

u/l

0.23

Other specified/unspecified arthritis

106

557

1.91

9.04

1.1

1.19

1.05

u/l

0.84

237

Non-allergic asthma (mode), excluding more controls

306

2.24

9.01

1.0

0.98

1.07

u/l

1.44

137

Disorders of mineral metabolism

133

2.96

8.92

1.1

1.0

0.94

1.14

u/l

2.23

Disorders of lipoprotein metabolism and other lipidaemias

257

1060

1.53

8.91

1.1

1.08

1.11

u/l

0.27

131

506

Complications of medical and surgical care

259

1641

1.50

8.87

1.1

1.09

1.08

u/l

0.08

114

740

Traumatic subdural haemorrhage

4.69

8.83

1.3

1.0

0.98

1.30

u/l

—

Viral meningitis

3.46

8.80

1.2

1.0

1.13

1.04

u/l

0.41

Dermatitis and eczema

420

1993

1.38

8.78

1.1

1.07

u/l

0.02

183

901

Cauda equina syndrome

6.17

8.70

1.1

1.0

1.04

1.13

u/l

—

Benign neoplasms

409

1640

1.39

8.69

1.1

1.13

1.05

u/l

0.41

183

724

Disorders of muscles

163

2.72

8.65

1.0

1.1

0.97

1.14

u/l

2.30

Hydrocephalus

3.26

8.61

1.1

1.0

1.26

1.17

u/l

0.26

Non-follicular lymphoma, hilmo, excluding all cancers

131

2.92

8.53

1.3

1.1

1.20

1.09

u/l

0.44

Other and unspecified hydrocephalus

5.63

8.53

1.2

1.0

1.36

1.11

u/l

—

Undetermined asthma

199

2.52

8.51

1.1

1.0

1.04

1.11

u/l

0.33

Mixed connective tissue disease

126

2.97

8.51

1.1

1.32

1.07

u/l

0.53

Personality disorders, excluding more controls

115

634

1.82

8.48

1.1

1.02

1.05

u/l

0.38

274

Undetermined asthma, excluding more controls

200

2.51

8.43

1.1

1.0

1.04

1.09

u/l

0.24

Unknown and unspecified causes of morbidity

106

3.13

8.37

1.2

1.0

1.04

1.13

u/l

0.42

Myopia

307

2.20

8.34

1.1

0.99

1.05

u/l

0.38

130

Explicit Sepsis

123

666

1.77

8.30

1.1

1.19

1.04

u/l

1.41

309

Constipation

291

1433

1.46

8.26

1.1

1.13

1.07

u/l

0.55

122

659

Neoplasms

354

1342

1.42

8.19

1.1

1.08

1.03

u/l

0.83

158

564

Hypertensive diseases

319

1256

1.44

8.16

1.1

1.09

u/l

0.00

133

589

Anterior Iridocyclitis

431

1.98

8.10

1.2

1.1

1.07

u/l

0.00

201

Non-follicular lymphoma

135

2.83

8.10

1.3

1.0

1.20

1.19

u/l

0.03

Asthma, hospital admissions , main diagnosis only

313

1974

1.42

8.09

1.1

0.99

1.08

u/l

2.69

138

880

Complications of surgical and medical care, not elsewhere classified

358

1841

1.40

8.08

1.1

1.06

1.07

u/l

0.20

160

838

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

3.19

8.08

1.2

1.1

0.96

1.12

u/l

2.14

Nonorganic sleeping disorders, excluding more controls

384

2.04

8.07

1.1

1.03

1.06

u/l

0.25

170

Paracetamol of NSAID medication

186

2.15

7.99

1.0

1.1

1.02

1.11

u/l

0.62

Voice disturbances

518

1.88

7.94

1.0

1.1

1.01

1.09

u/l

1.02

234

Delirium, not induced by alcohol and other psychoactive substances

120

2.93

7.93

1.1

1.0

1.10

1.18

u/l

0.30

Hypopituitarism

148

2.73

7.92

1.1

1.17

1.05

u/l

0.26

Other enthesopathy of foot (+metatarsalgia)

171

2.59

7.91

1.0

1.1

1.01

1.15

u/l

1.42

Fourth [trochlear] nerve palsy

4.70

7.91

1.0

1.1

1.36

1.16

u/l

—

Hypertension

317

1255

1.43

7.89

1.1

1.09

u/l

0.00

132

589

Asthma-related pneumonia or sepsis

111

619

1.80

7.87

1.1

1.11

1.06

u/l

0.18

272

Asthma, hospital admissions 3, pneumonia

111

619

1.80

7.87

1.1

1.11

1.06

u/l

0.18

272

Generalized anxiety disorder

388

2.02

7.87

1.1

0.95

1.08

u/l

1.70

165

Metatarsalgia

155

2.66

7.79

1.0

1.1

1.02

1.15

u/l

1.08

Other/unspecified enthesopathies of lower limb, excluding foot

117

2.93

7.69

1.1

1.01

1.12

u/l

0.75

Other disorders of nervous system

3.15

7.68

1.3

1.0

1.01

1.13

u/l

0.67

Diseases of pulp and periapical tissues

134

796

1.69

7.66

1.1

1.04

1.11

u/l

0.58

377

Disturbances of smell and taste

3.75

7.64

1.1

1.11

1.13

u/l

—

Asthma-related pneumonia

110

618

1.78

7.62

1.1

1.11

1.06

u/l

0.18

271

Urticaria and erythema

151

928

1.63

7.58

1.1

1.15

1.05

u/l

0.65

409

Abnormal findings on examination of blood, without diagnosis

141

798

1.66

7.46

1.1

1.04

1.11

u/l

0.67

378

Other diseases of intestines

421

1816

1.35

7.46

1.1

0.99

1.08

u/l

3.02

174

835

Diseases of the skin and subcutaneous tissue

410

1513

1.36

7.44

1.1

1.03

1.08

u/l

0.95

171

700

Polyarteritis nodosa and related conditions

6.04

7.41

1.0

1.13

1.11

u/l

—

Systemic lupus erythematosus

3.38

7.40

1.1

1.02

1.08

u/l

—

Propionic acid derivatives

115

319

1.82

7.40

1.1

1.06

1.10

u/l

0.28

121

Immunodeficiency with predominantly antibody defects

4.19

7.30

1.3

1.1

1.03

1.11

u/l

—

Dental caries

535

1.82

7.28

1.1

1.01

1.12

u/l

0.67

257

Other disorders of ear

310

1472

1.41

7.22

1.1

1.10

1.08

u/l

0.11

137

676

Benign neoplasm of brain and other parts of central nervous system

116

2.87

7.22

1.1

0.99

1.07

u/l

0.85

All influenza

478

1.87

7.20

1.1

1.05

1.04

u/l

0.01

226

Complications of procedures, not elsewhere classified

287

1758

1.41

7.18

1.1

1.04

1.08

u/l

0.35

133

801

Other heart diseases

199

860

1.53

7.18

1.1

1.06

1.08

u/l

0.15

389

Restless leg syndrome

217

2.32

7.14

1.1

1.01

1.12

u/l

1.07

114

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

204

1357

1.50

7.13

1.1

1.10

1.08

u/l

0.16

605

Benign neoplasm of brain and other parts of central nervous system

118

2.82

7.01

1.1

0.99

1.17

u/l

1.69

Cluster headache, strict, including avohilmo

119

2.80

6.91

1.1

1.06

u/l

0.03

Hypothyroidism, strict autoimmune, 3 medication purchases required

313

1538

1.39

6.90

1.1

1.11

1.04

u/l

1.11

145

659

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

119

2.79

6.90

1.0

1.1

1.01

1.20

u/l

1.11

Other functional intestinal disorders

141

831

1.62

6.87

1.1

1.09

1.07

u/l

0.14

385

Dentinal caries

469

1.85

6.87

1.1

1.03

1.12

u/l

0.51

221

Systemic lupus erythematosus, unspecified

3.39

6.85

1.0

1.1

1.03

1.06

u/l

—

Other disorders of bladder

166

2.48

6.82

1.1

0.94

1.10

u/l

1.82

Hypermetropia

137

2.65

6.80

1.1

1.01

1.09

u/l

0.38

Other septicaemia

102

571

1.76

6.77

1.1

1.14

1.05

u/l

1.08

262

Disorders of conjunctiva

312

1898

1.38

6.76

1.1

1.04

1.07

u/l

0.40

134

840

Diffuse large B-cell lymphoma

3.66

6.76

1.2

1.0

1.17

1.18

u/l

—

Other sleep disorders

161

2.50

6.74

1.1

1.0

1.08

1.13

u/l

0.17

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

5.10

6.73

1.0

1.06

1.05

u/l

—

Brain glioblastoma and astrocytoma

5.10

6.73

1.0

1.06

1.15

u/l

—

SLE, strict definition

3.25

6.72

1.1

1.02

1.09

u/l

—

SLE, ICD10

3.25

6.72

1.1

1.02

1.09

u/l

—

Deforming dorsopathies

497

1.82

6.70

1.0

1.1

0.99

1.08

u/l

1.40

214

Septicaemia

113

641

1.70

6.65

1.1

1.22

1.04

u/l

1.70

290

Giant cell arteritis

3.74

6.65

1.3

1.1

0.99

1.19

u/l

1.33

Acute and subacute iridocyclitis

406

1.90

6.63

1.2

1.1

1.07

u/l

0.00

186

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

3.59

6.60

1.2

1.0

1.17

1.14

u/l

—

Diffuse large B-cell lymphoma, helper endpoint

3.59

6.60

1.2

1.0

1.17

1.14

u/l

—

Speech and linguistic disorders, excluding more controls

164

2.43

6.59

1.0

1.1

1.22

1.00

u/l

0.78

Chronic rhinitis, nasopharyngitis and pharyngitis

119

715

1.67

6.59

1.1

1.13

1.06

u/l

0.38

303

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

188

1256

1.50

6.58

1.1

1.09

1.08

u/l

0.09

563

Soft tissue disorders related to use, overuse and pressure

429

1.87

6.54

1.1

1.10

u/l

0.03

198

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

135

830

1.61

6.53

1.0

1.1

0.95

1.04

u/l

2.89

358

Acute upper respiratory infections of multiple and unspecified sites

291

1572

1.39

6.52

1.1

0.96

1.09

u/l

4.19

127

697

Cluster headache, wide,, including avohilmo

123

2.71

6.51

1.1

1.06

u/l

0.03

Other disorders of eyelid

110

628

1.70

6.45

1.1

1.11

1.09

u/l

0.11

302

Temporal arteritis

3.96

6.45

1.3

1.1

0.97

1.22

u/l

1.64

Giant cell arteritis with polymyalgia rheumatica

3.96

6.45

1.3

1.1

0.97

1.13

u/l

1.09

Disorders of calcium metabolism

2.94

6.43

1.1

0.95

1.18

u/l

1.83

Other shoulder lesions

165

2.44

6.42

1.1

1.08

1.15

u/l

0.31

Tinnitus

455

1.83

6.35

1.1

1.08

1.07

u/l

0.06

211

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

3.61

6.32

1.4

1.0

1.36

1.15

u/l

0.35

Use of pramipexole

336

1.97

6.32

1.1

1.00

1.10

u/l

1.45

170

Dermatographic urticaria

155

2.47

6.27

1.1

1.09

1.10

u/l

0.01

Other diseases of blood and blood-forming organs, wide

400

1.88

6.26

1.1

1.09

u/l

0.03

183

Early lumbar disc prolapse, operated

211

2.24

6.25

1.1

1.05

1.04

u/l

0.09

Degenerative diseases of the nervous system

234

2.03

6.23

1.1

1.00

1.15

u/l

2.52

119

Spondyloarthritis

331

1.97

6.22

1.1

1.28

1.08

u/l

0.63

165

Other and unspecified mononeuropathies of upper limb

3.70

6.21

1.2

1.1

1.06

1.15

u/l

0.54

Cardiac arrhythmias

248

1156

1.42

6.21

1.1

1.03

1.09

u/l

0.62

114

515

Autoimmune thyroiditis

4.03

6.20

1.3

1.0

0.90

1.12

u/l

—

Anti-inflammatory and antirheumatic products, non-steroids

110

319

1.74

6.20

1.0

1.1

1.03

1.10

u/l

0.57

121

Other bacterial diseases

308

1562

1.36

6.16

1.1

1.14

1.06

u/l

1.19

155

702

Urticaria

124

768

1.62

6.14

1.1

1.19

1.06

u/l

0.65

336

COPD/asthma/ILD related infections

406

1544

1.32

6.08

1.1

1.05

1.08

u/l

0.36

168

702

COPD/asthma related infections

406

1544

1.32

6.08

1.1

1.05

1.08

u/l

0.36

168

702

Injuries to the ankle and foot

277

1839

1.37

6.02

1.1

1.00

1.07

u/l

1.44

122

810

Other and unspecified types of non-Hodgkin lymphoma, hilmo

3.48

6.02

1.4

1.0

1.36

1.13

u/l

0.39

Other metabolic disorders

274

2.05

6.01

1.2

1.1

0.99

1.10

u/l

1.07

117

Other and unspecified trigeminal disorders

4.90

6.00

1.1

0.98

1.15

u/l

—

418

1691

1.31

5.95

1.1

1.00

1.10

u/l

2.29

175

773

Disorders of lens

195

835

1.48

5.93

1.1

1.10

1.11

u/l

0.05

428

Benign neoplasm of other and unspecified endocrine glands

216

2.19

5.92

1.1

1.20

1.06

u/l

0.35

102

Bronchitis

393

1970

1.31

5.92

1.1

0.99

1.08

u/l

2.08

165

896

Pain and other conditions associated with female genital organs and menstrual cycle

105

603

1.68

5.91

1.1

1.06

1.01

u/l

0.43

248

Chronic periapical parodontitis

387

1.87

5.90

1.1

1.04

1.07

u/l

0.19

189

Anosmia

6.23

5.87

1.2

1.1

1.18

1.00

u/l

—

Other peripheral vascular diseases

148

2.45

5.86

1.1

1.04

1.13

u/l

0.73

Other specified/unspecified systemic involvement of connective tissue

107

2.73

5.86

1.1

1.39

1.09

u/l

0.48

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

133

848

1.57

5.85

1.1

1.04

1.05

u/l

0.12

357

Other symptoms and signs involving the circulatory and respiratory systems

113

2.67

5.82

1.1

1.07

1.14

u/l

0.43

Non-Hodgkin lymphoma, all

3.81

5.82

1.2

1.0

1.83

1.10

u/l

—

Diseases of pulp and periapical tissues, including avohilmo

411

1637

1.31

5.81

1.1

1.04

1.08

u/l

0.83

163

739

Hypokalaemia

167

2.35

5.80

1.2

1.1

0.95

1.14

u/l

2.44

Persons with potential health hazards related to communicable diseases

173

1160

1.48

5.80

1.1

1.02

1.04

u/l

0.26

496

Specific development disorders of speech and language

120

2.59

5.78

1.0

1.1

1.33

1.00

u/l

0.95

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

179

782

1.49

5.76

1.0

1.1

0.99

1.00

u/l

0.21

297

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

185

794

1.48

5.75

1.1

1.04

1.09

u/l

0.43

349

Dental pulpitis 1

411

1640

1.30

5.75

1.1

1.04

1.08

u/l

0.85

164

740

Conjunctivitis

286

1839

1.36

5.74

1.1

1.00

1.07

u/l

1.46

121

805

Vertical strabismus

3.27

5.74

1.1

1.11

1.08

u/l

—

Dental pulpitis 4

411

1640

1.30

5.74

1.1

1.04

1.08

u/l

0.85

164

740

Other and unspecified coagulation defects

109

2.69

5.67

1.1

1.02

1.07

u/l

0.41

Other specified/unspecified inflammatory spondylopathies

2.90

5.62

1.1

1.43

1.07

u/l

—

Fenamates

198

2.02

5.62

1.1

1.00

1.17

u/l

1.43

Other diseases of jaws

133

2.50

5.61

1.1

1.0

1.08

1.11

u/l

0.07

Meralgia paraesthetica

3.43

5.60

1.0

1.1

1.10

1.07

u/l

—

Other specified disorders of muscle

3.85

5.55

1.1

1.0

0.99

1.08

u/l

—

Circumscribed brain atrophy

4.87

5.51

1.0

1.00

1.15

u/l

—

Exposure to unspecified factor

350

2074

1.31

5.48

1.1

1.05

1.07

u/l

0.19

169

917

Transport accidents

173

1048

1.47

5.44

1.0

1.1

1.04

1.08

u/l

0.29

474

Dystonia

100

2.72

5.43

1.1

1.00

1.07

u/l

0.53

Benign neoplasm: Pituitary gland, craniopharyngeal duct

106

2.67

5.41

1.2

1.1

1.26

1.07

u/l

0.30

Other disorders of bone

472

1.74

5.40

1.0

1.1

1.08

1.06

u/l

0.18

214

Dental pulpitis 3, only avohilmo

261

1.88

5.36

1.0

0.91

0.97

u/l

1.64

103

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

2.88

5.36

1.2

1.1

0.92

1.07

u/l

—

Spondylolisthesis/Spondylolysis

259

2.01

5.35

1.0

1.1

0.99

1.12

u/l

1.77

127

Glaucoma suspect

571

1.67

5.34

1.1

1.04

1.08

u/l

0.61

270

Inflammatory diseases of female pelvic organs

242

1323

1.38

5.34

1.0

1.1

1.07

1.05

u/l

0.19

572

Injury, poisoning and certain other consequences of external causes

231

823

1.41

5.32

1.1

1.05

1.09

u/l

0.39

104

351

Myositis

3.89

5.27

1.0

1.1

0.99

1.19

u/l

—

Chronic iridocyclitis

102

2.67

5.25

1.2

1.1

1.27

1.06

u/l

0.36

Astigmatism

114

2.56

5.20

1.1

0.93

1.04

u/l

—

Other obstetric conditions, not elsewhere classified

180

807

1.45

5.16

1.0

1.1

1.01

1.00

u/l

0.08

307

Acute bronchitis

127

810

1.54

5.14

1.1

1.06

1.04

u/l

0.08

361

Asthma/COPD (KELA code 203)

350

1900

1.30

5.12

1.1

1.01

1.08

u/l

1.85

150

859

Herpesviral [herpes simplex] infections

237

2.04

5.09

1.2

1.1

1.07

1.11

u/l

0.14

118

Genitourinary diseases

241

873

1.39

5.08

1.1

1.04

1.08

u/l

0.36

110

416

Injuries to the head

396

2021

1.28

5.02

1.1

1.07

1.06

u/l

0.07

179

906

Dental pulpitis 3

279

1.81

5.00

1.0

1.1

0.91

1.02

u/l

2.22

115

Keratitis

122

794

1.54

4.97

1.0

1.1

1.08

1.04

u/l

0.30

349

Injuries to the wrist and hand

361

2033

1.29

4.97

1.1

1.03

1.07

u/l

0.61

159

913

Benign neoplasm of colon, rectum, anus and anal canal

155

954

1.47

4.97

1.2

1.1

1.21

1.09

u/l

0.28

462

Polymyalgia rheumatica

154

2.28

4.94

1.1

1.03

1.17

u/l

1.34

Ovarian cyst

167

660

1.47

4.94

1.1

1.00

1.04

u/l

0.45

276

Dental pulpitis 4, only avohilmo

410

1681

1.27

4.92

1.1

1.04

1.08

u/l

0.79

163

761

Unspecified/other endometriosis

289

1.91

4.91

1.0

1.1

0.87

0.99

u/l

4.40

109

Vestibular neuronitis

161

2.25

4.91

1.0

1.24

1.12

u/l

0.17

Postprocedural endocrine and metabolic disorders, not elsewhere classified

255

1.97

4.86

1.2

1.0

0.94

1.11

u/l

2.66

109

Other disorders of binocular vision

4.36

4.85

1.1

0.95

1.16

u/l

—

Bacterial meningitis

3.02

4.84

1.0

1.18

1.07

u/l

—

Persistent mood disorders

399

1.76

4.82

1.1

0.99

1.08

u/l

0.80

183

Other diseases of the respiratory system

284

1.91

4.80

1.0

1.1

0.97

1.11

u/l

2.13

137

Other respiratory disorders and diseases

284

1.91

4.80

1.0

1.1

0.97

1.11

u/l

2.13

137

Benign neoplasm: Pituitary gland, craniopharyngeal duct

113

2.50

4.80

1.2

1.1

1.26

1.10

u/l

0.25

3.20

4.78

1.0

1.1

1.00

1.08

u/l

—

Other symptoms and signs involving the digestive system and abdomen

278

1.91

4.75

1.1

1.09

1.10

u/l

0.04

126

Scleritis and episcleritis

126

2.40

4.73

1.0

1.1

1.05

1.07

u/l

0.08

Reimbursement for rheumatic diseases

189

1351

1.40

4.72

1.1

1.14

1.06

u/l

0.65

601

Mycoses

545

1.64

4.72

1.1

1.05

1.07

u/l

0.14

243

Episcleritis

108

2.52

4.71

1.0

1.1

1.06

1.05

u/l

0.05

Respiratory insufficiency

2.95

4.69

1.0

0.98

1.24

u/l

—

Injuries to the neck

577

1.62

4.68

1.1

1.01

1.05

u/l

0.55

260

Other disorders of skin and subcutaneous tissue

198

1310

1.39

4.67

1.1

1.06

1.08

u/l

0.17

605

Other viral diseases

121

796

1.52

4.67

1.1

0.96

1.04

u/l

1.98

352

Dentofacial anomalies [including malocclusion]

113

727

1.54

4.64

1.1

1.04

1.05

u/l

0.05

321

Deviated nasal septum

102

648

1.58

4.64

1.1

1.01

1.13

u/l

1.22

312

Benign neoplasm of colon, rectum, anus and anal canal

151

738

1.46

4.63

1.2

1.1

1.22

1.06

u/l

0.37

340

Other diseases of hard tissues of teeth

230

1265

1.36

4.63

1.0

1.1

1.08

1.09

u/l

0.06

577

Oxicams

240

1.76

4.59

1.1

1.06

1.13

u/l

0.34

Obstructive hydrocephalus

4.47

4.58

1.2

1.0

1.45

1.10

u/l

—

Benign neoplasm: Colon

125

816

1.50

4.58

1.2

1.1

1.24

1.07

u/l

0.35

397

Intracerebral haemorrhage

128

2.35

4.56

1.0

1.1

1.09

1.18

u/l

0.38

Trochanteric bursitis

193

2.08

4.54

1.1

1.07

1.14

u/l

0.47

Disorders of adult personality and behaviour

126

844

1.50

4.54

1.1

1.04

1.03

u/l

0.14

363

Dental pulpitis 1, only avohilmo

407

1686

1.26

4.53

1.1

1.04

1.08

u/l

0.77

161

764

Disorders of speech understanding and production

2.81

4.50

1.0

1.39

0.98

u/l

—

Disorders of orbit

2.67

4.49

1.1

0.97

1.08

u/l

—

Presence of other functional implants

139

669

1.47

4.42

1.1

1.08

1.07

u/l

0.02

326

Speech and linguistic disorders

200

2.03

4.41

1.0

1.1

1.22

0.99

u/l

0.86

Faecal incontinence

124

2.35

4.40

1.3

1.1

0.98

1.13

u/l

0.72

Chronic laryngitis and laryngotracheitis

230

1.96

4.38

1.1

1.27

1.15

u/l

0.24

106

Horner syndrome

4.31

4.38

1.1

1.0

1.15

1.16

u/l

—

Ankylosing spondylitis

150

2.21

4.36

1.1

1.45

1.08

u/l

0.62

316

1538

1.29

4.34

1.1

1.13

1.08

u/l

0.47

130

698

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

316

1538

1.29

4.34

1.1

1.13

1.08

u/l

0.47

130

698

Injuries to the knee and lower leg

429

1975

1.24

4.33

1.1

1.05

1.07

u/l

0.18

204

870

Any dementia, excluding more controls

240

1.80

4.33

1.1

1.05

1.11

u/l

0.36

117

Diarrhoea and gastroenteritis of presumed infectious origin

253

1748

1.32

4.30

1.1

1.05

1.06

u/l

0.10

112

782

Thyroiditis, ILD-related definition

218

1.98

4.29

1.1

1.02

1.08

u/l

0.39

112

Phobic anxiety disorders

326

1.79

4.23

1.1

0.96

1.05

u/l

1.88

149

Other abnormal immunological findings in serum

3.66

4.22

1.0

1.1

0.97

1.10

u/l

—

Other retinal disorders

159

903

1.42

4.21

1.1

1.05

u/l

0.03

436

Statin medication

276

1183

1.31

4.20

1.1

1.20

1.07

u/l

1.36

125

531

Spondylopathies (FG)

327

1.78

4.20

1.1

1.32

1.04

u/l

0.83

144

Other/unspecified disorders of vestibular function

2.93

4.18

1.1

1.0

1.06

u/l

—

Medial epicondylitis

2.93

4.17

1.1

1.14

1.10

u/l

—

Disorders of synovium and tendon in diseases classified elsewhere

4.12

4.17

1.0

0.90

1.14

u/l

—

Sleep disorders, other/unspecified

2.69

4.17

1.1

0.99

1.05

u/l

—

Other medical care

104

666

1.53

4.15

1.1

1.36

1.04

u/l

0.62

301

Benign neoplasm of other and unspecified endocrine glands

249

1.90

4.15

1.1

1.20

1.11

u/l

0.22

128

Psychotic depression

2.54

4.13

1.0

1.54

1.18

u/l

—

Diseases of oral cavity, salivary glands and jaws

321

1285

1.28

4.12

1.1

1.04

1.09

u/l

0.62

135

587

Other arrhythmias

219

1254

1.34

4.10

1.1

1.04

1.08

u/l

0.50

560

Infections with a predominantly sexual mode of transmission

139

970

1.44

4.09

1.1

1.02

u/l

0.08

416

Retinal vascular occlusion

148

2.17

4.07

1.2

1.1

0.98

1.19

u/l

2.15

Intestinal infectious diseases

328

2018

1.27

4.07

1.1

1.03

1.06

u/l

0.38

152

893

Other specified/unspecified soft tissue disorders

2.87

4.06

1.0

1.04

1.20

u/l

—

Other symptoms and signs involving general sensations and perceptions

3.21

4.06

1.1

1.0

1.01

1.09

u/l

—

Influenza and pneumonia

377

1988

1.25

4.03

1.1

1.11

1.06

u/l

0.60

157

902

Behavioural syndromes associated with physiological disturbances and physical factors

128

882

1.45

4.03

1.1

1.07

1.04

u/l

0.22

377

Paroxysmal tachycardia

386

1.65

4.02

1.1

1.05

u/l

0.04

173

Other coagulation defects

156

2.13

3.99

1.1

1.01

1.06

u/l

0.40

Otalgia

156

2.13

3.99

1.1

1.06

1.11

u/l

—

Other and unspecified myopathies

130

2.24

3.99

1.2

1.1

1.33

1.21

u/l

0.13

Secondary hypertension

110

2.35

3.98

1.0

1.1

1.00

1.07

u/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

151

1076

1.40

3.94

1.1

1.00

1.05

u/l

0.82

461

Persons encountering health services in other circumstances

124

855

1.45

3.90

1.1

1.00

1.05

u/l

0.59

380

Retinal vascular disorders

151

2.13

3.89

1.2

1.1

0.98

1.19

u/l

2.09

Disorders of skin appendages

175

1283

1.37

3.88

1.1

0.99

1.05

u/l

1.11

559

Allergic asthma (mode), excluding more controls

579

1.55

3.87

1.1

1.0

0.93

1.05

u/l

3.19

227

Contact with and exposure to communicable diseases

141

995

1.41

3.85

1.1

0.98

1.02

u/l

0.60

425

Benign neoplasm: Colon

125

659

1.46

3.85

1.2

1.1

1.24

1.07

u/l

0.36

314

Allergic asthma (mode)

581

1.54

3.82

1.1

1.0

0.93

1.05

u/l

3.37

228

Any dementia

265

1.70

3.81

1.1

1.05

1.12

u/l

0.45

139

Conjunctivitis (acute, non atopic)

639

1.52

3.79

1.1

1.03

1.05

u/l

0.12

287

Localized swelling, mass and lump of skin and subcutaneous tissue

546

1.56

3.78

1.1

1.08

1.07

u/l

0.09

254

Other diseases of pleura

102

602

1.50

3.77

1.0

1.1

1.06

1.07

u/l

0.06

289

Drug-induced cataract

3.37

3.77

1.2

1.0

0.94

1.13

u/l

—

Procreative management

134

794

1.43

3.76

1.1

1.01

1.07

u/l

0.97

346

Irregular menses

202

1231

1.33

3.75

1.1

0.98

1.06

u/l

2.55

508

Other peripheral vertigo

154

2.09

3.72

1.2

1.0

1.06

1.12

u/l

0.42

Other arthrosis

152

780

1.40

3.70

1.1

1.04

1.12

u/l

0.89

371

Dislocation, sprain and strain of joints and ligaments at neck level

409

1.64

3.69

1.0

1.1

1.03

1.05

u/l

0.28

178

Personality disorders

115

792

1.46

3.69

1.1

1.02

1.03

u/l

0.15

337

Calcific tendinitis of shoulder

2.38

3.65

1.0

1.1

1.02

1.13

u/l

0.77

Nonorganic sleeping disorders

496

1.58

3.64

1.1

1.03

1.06

u/l

0.21

220

Diabetic neuropathy

148

2.09

3.62

1.1

0.90

1.06

u/l

—

Osteoporosis

334

1.69

3.59

1.2

1.1

1.06

1.10

u/l

0.25

164

Disorders of vitreous body

120

821

1.43

3.55

1.1

1.01

1.09

u/l

2.06

396

Other heart diseases, wide

346

1732

1.24

3.54

1.1

1.05

1.08

u/l

0.41

157

787

Complications of other internal prosthetic devices, implants and grafts

2.83

3.53

1.2

1.1

1.42

1.22

u/l

—

Bacterial pneumonia (organism specified)

118

749

1.44

3.52

1.1

1.19

1.05

u/l

0.95

344

Other nutritional deficiencies

232

1759

1.29

3.52

1.1

1.18

1.05

u/l

0.39

100

781

Arthropathies in other diseases classified elsewhere

2.63

3.48

1.6

1.1

1.43

1.16

u/l

—

Other problems related to primary support group, including family circumstances

294

1.73

3.47

1.1

0.95

1.02

u/l

0.90

131

Dementia

310

1.61

3.45

1.1

1.06

1.09

u/l

0.18

167

Coagulation defects, purpura and other haemorrhagic conditions

394

1.63

3.44

1.1

1.06

1.09

u/l

0.31

177

Appendectomy

238

1791

1.28

3.42

1.1

1.04

1.07

u/l

0.26

803

Nontraumatic intracranial haemmorrhage

244

1.81

3.42

1.0

1.1

1.15

1.11

u/l

0.22

128

Bacterial pneumonia, not elsewhere classified

105

637

1.46

3.42

1.1

1.19

1.04

u/l

1.02

296

Other hearing loss

350

1.66

3.41

1.1

1.05

1.09

u/l

0.23

167

Malignant neoplasm of breast

787

0.64

3.40

1.0

1.1

1.09

u/l

0.01

359

Glaucoma

129

807

1.40

3.40

1.1

1.10

1.07

u/l

0.18

401

Need for other prophylactic measures

107

2.26

3.39

1.2

1.1

1.27

1.10

u/l

0.65

Senile cataract

156

706

1.37

3.38

1.1

1.12

1.11

u/l

0.07

365

Asthma and allergy

308

1.70

3.37

1.2

1.0

0.90

1.06

u/l

2.56

124

Aneurysms, operations, SAH

238

1.81

3.37

1.0

1.1

1.14

1.10

u/l

0.17

122

Disorders of vitreous body and globe

122

843

1.41

3.37

1.1

1.01

1.09

u/l

2.02

406

Sleep disorders

554

1.52

3.37

1.1

1.03

1.06

u/l

0.25

249

Specific personality disorders

677

1.47

3.33

1.1

0.98

1.03

u/l

0.87

289

Exclusions for E4_PCOS_CONSORTIUM

277

1377

1.26

3.33

1.1

1.05

1.04

u/l

0.04

127

589

Problems related to lifestyle

225

1.83

3.32

1.1

0.95

1.05

u/l

1.44

107

Unspecified fall

141

1020

1.37

3.31

1.1

1.05

1.08

u/l

0.20

455

Bacterial pneumoniae

112

693

1.43

3.30

1.1

1.19

1.04

u/l

0.96

321

Other/unspecified soft tissue disorders related to use, overuse and pressure

2.94

3.30

1.1

1.0

1.09

1.10

u/l

—

Asthma and allergy, excluding more controls

310

1.69

3.30

1.2

1.0

0.90

1.05

u/l

2.45

124

Sequelae of external causes of morbidity and mortality

453

1.57

3.30

1.1

1.11

1.08

u/l

0.08

213

Dementia, including avohilmo

346

1.56

3.30

1.1

1.06

1.09

u/l

0.19

174

Exposure to other specified factors

257

1911

1.26

3.28

1.1

0.98

1.08

u/l

3.32

108

858

Other specified/unspecified hearing loss

122

2.14

3.25

1.0

1.1

1.04

1.17

u/l

0.78

Other and unspecified mood [affective] disorders

184

1.91

3.24

1.1

1.0

0.96

1.03

u/l

0.89

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

177

1.93

3.23

1.1

1.05

1.13

u/l

0.40

Immunodeficiencies

103

2.25

3.23

1.3

1.1

1.04

1.07

u/l

—

Other skin changes

249

1.77

3.22

1.2

1.1

0.99

1.13

u/l

1.10

126

Social phobias

220

1.83

3.22

1.0

1.1

0.93

1.02

u/l

1.42

Internal derangement of knee

123

880

1.40

3.20

1.0

1.1

0.96

1.10

u/l

2.31

395

Congenital malformations of the nervous system

2.89

3.20

1.0

1.1

1.25

1.08

u/l

—

Acute lymphadenitis

150

2.01

3.20

1.2

1.1

0.94

1.06

u/l

1.48

Divergent concomitant strabismus

157

1.98

3.19

1.1

1.07

1.10

u/l

0.10

Plantar fascial fibromatosis

157

1.98

3.19

1.1

1.06

1.14

u/l

0.46

Rash and other nonspecific skin eruption

164

1.96

3.18

1.0

1.01

1.14

u/l

0.64

Meniscus derangement

171

878

1.33

3.18

1.1

1.02

1.11

u/l

1.06

407

Other CVD (FINNGEN)

111

2.06

3.18

1.3

1.1

1.08

1.10

u/l

0.06

Retinal breaks without detachment

258

1.75

3.16

1.1

0.98

1.12

u/l

2.62

133

Dental caries 3 and operation codes

303

1250

1.24

3.14

1.1

1.05

1.09

u/l

0.43

131

586

Hyperkinetic disorders, excluding more controls

245

1.75

3.11

1.0

1.1

0.94

0.99

u/l

0.36

Excessive attrition of teeth

144

570

1.37

3.10

1.0

1.1

1.11

1.02

u/l

0.59

238

Alzheimer’s disease (Late onset), excluding more controls

2.86

3.10

1.3

1.1

1.06

1.34

u/l

—

Conductive and sensorineural hearing loss

211

1135

1.29

3.08

1.1

1.12

1.10

u/l

0.20

100

545

Pneumonia, organism unspecified

291

1701

1.24

3.06

1.1

1.15

1.06

u/l

1.00

123

774

Dental pulpitis 2, only avohilmo

232

928

1.28

3.06

1.1

1.07

1.08

u/l

0.05

108

440

Other cataract

104

562

1.43

3.06

1.1

0.99

1.06

u/l

1.24

291

Other complications of surgical and medical care, not elsewhere classified

181

1.89

3.04

1.2

1.1

0.96

1.14

u/l

—

Obsessive-compulsive disorder

174

1.91

3.04

1.1

1.03

u/l

0.03

Sicca syndrome [Sjögren]

153

1.97

3.04

1.1

1.12

1.11

u/l

0.01

Diseases of appendix

264

1932

1.25

3.04

1.1

1.06

1.08

u/l

0.19

115

879

Other and unspecified epidermal thickening

2.91

3.03

1.1

1.0

0.96

1.07

u/l

—

All influenza (not pneumonia)

315

1.66

3.01

1.1

1.10

1.05

u/l

0.13

156

Covid-19 suspected case

553

1.49

3.00

1.1

1.08

1.04

u/l

0.19

235

Polyarthropathies

223

1167

1.27

2.99

1.1

1.15

1.09

u/l

0.46

103

515

Appendicitis, broad definition

262

1928

1.24

2.97

1.1

1.06

1.08

u/l

0.19

115

879

Dental caries 3

271

1108

1.25

2.97

1.1

1.05

1.07

u/l

0.46

117

526

Vasomotor and allergic rhinitis

138

1008

1.35

2.96

1.1

1.00

1.08

u/l

0.98

423

Convergent concomitant strabismus

134

2.03

2.96

1.1

1.09

1.04

u/l

0.16

Pulmonary embolism

442

1.54

2.95

1.2

1.1

1.06

1.09

u/l

0.19

201

Infections of the skin and subcutaneous tissue

190

1470

1.29

2.93

1.1

0.99

1.08

u/l

1.30

662

Other congenital malformations of circulatory system

2.85

2.92

1.0

1.05

1.10

u/l

—

Pulmonary heart disease, diseases of pulmonary circulation

475

1.52

2.92

1.2

1.1

1.08

1.09

u/l

0.07

218

Diseases of salivary glands

380

1.58

2.92

1.1

1.00

1.08

u/l

1.03

185

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

198

1522

1.28

2.91

1.1

1.00

1.06

u/l

1.30

663

Endometriosis of pelvic peritoneum

454

1.53

2.90

1.0

1.1

0.93

1.02

u/l

1.28

178

Pulmonary heart disease

444

1.53

2.90

1.2

1.1

1.06

1.09

u/l

0.21

203

Continuous positive airway pressure

280

1.64

2.89

1.1

1.80

1.09

u/l

0.44

153

Acute tubulo-interstitial nephritis

183

1258

1.29

2.85

1.1

1.03

1.05

u/l

0.26

554

Excessive vomiting in pregnancy

237

1.74

2.84

1.1

1.00

1.06

u/l

0.45

Abnormal weight loss

150

1.94

2.84

1.2

1.0

1.18

1.16

u/l

0.07

Dental caries 1 and operation codes

282

1169

1.24

2.84

1.1

1.05

1.09

u/l

0.52

126

546

Other acute lower respiratory infections

158

1148

1.31

2.83

1.1

1.04

1.07

u/l

0.26

522

Dental caries 1, only avohilmo

256

1047

1.25

2.83

1.1

1.06

1.07

u/l

0.13

114

498

Endometriosis

142

627

1.35

2.83

1.0

1.1

1.01

1.04

u/l

0.24

259

Congenital malformations, deformations and chromosomal abnormalities

225

1718

1.26

2.82

1.1

1.05

1.06

u/l

0.09

103

738

Dental pulpitis 2

225

908

1.27

2.82

1.1

1.07

1.08

u/l

0.06

104

429

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

667

0.66

2.82

1.0

1.1

1.09

1.07

u/l

0.09

292

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

667

0.66

2.82

1.0

1.1

1.09

1.07

u/l

0.09

292

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

326

1893

1.21

2.79

1.1

1.15

1.06

u/l

1.08

140

855

Acute pharyngitis

382

1.56

2.79

1.1

0.97

1.04

u/l

0.74

183

Use of levodopa decarboxylase inhibitor

144

1.95

2.79

1.1

1.0

0.99

1.21

u/l

—

TMD related operations

417

1.54

2.78

1.1

1.01

1.06

u/l

0.46

193

Injuries to the shoulder and upper arm

247

1668

1.24

2.78

1.1

1.10

1.08

u/l

0.20

115

765

Malignant neoplasm of breast, HER2-negative

755

0.67

2.77

1.0

1.1

1.10

1.09

u/l

0.01

345

Oter anti-inflammatory and antirheumatic agents, non-steroids

187

1.63

2.77

1.1

1.14

u/l

0.01

Special screening examination for other diseases and disorders

117

2.06

2.76

1.2

1.0

1.01

1.14

u/l

0.63

Tonsillectomy and adenotomy

249

1396

1.24

2.76

1.1

0.98

1.04

u/l

1.26

116

583

Acute appendicitis, no complications

204

1609

1.27

2.76

1.0

1.1

1.03

1.07

u/l

0.43

716

Cerebral aneurysm, nonruptured

145

1.94

2.74

1.0

1.1

1.06

1.14

u/l

—

Peripheral artery disease

488

0.58

2.74

1.0

1.1

0.95

1.08

u/l

2.70

244

Mouth breathing

120

883

1.36

2.73

1.0

1.1

0.94

1.11

u/l

3.95

431

Other and unspecified anaemias

602

1.43

2.72

1.1

1.19

1.06

u/l

0.72

287

Other and unspecified erythematous conditions

2.52

2.71

1.1

1.02

1.12

u/l

—

Dental caries, including avohilmo

248

1017

1.25

2.69

1.1

1.06

1.07

u/l

0.11

110

482

Dental caries 1

248

1017

1.25

2.69

1.1

1.06

1.07

u/l

0.11

110

482

Sacroiliitis, not elsewhere classified

105

2.11

2.69

1.2

1.1

1.28

1.05

u/l

—

Acute appendicitis

247

1889

1.23

2.68

1.1

1.06

1.08

u/l

0.12

111

857

Other erythematous conditions

2.41

2.63

1.1

1.02

1.11

u/l

—

Endometriosis of rectovaginal septum and vagina

162

1.86

2.61

1.0

1.1

1.01

1.02

u/l

—

TMD related pain

2.17

2.61

1.0

1.1

1.01

1.06

u/l

—

Emotionally unstable personality disorder

368

1.55

2.60

1.1

0.95

1.03

u/l

1.48

160

Other anaemias

606

1.42

2.60

1.1

1.19

1.05

u/l

0.73

289

Adhesive capsulitis of shoulder

236

1.70

2.60

1.0

1.1

1.01

1.12

u/l

1.16

123

Secondary and unspecified malignant neoplasm of lymph nodes

134

1.95

2.60

1.2

1.0

1.13

1.19

u/l

0.16

Other superficial mycoses

2.92

2.59

1.3

1.1

1.03

1.12

u/l

—

Fracture of foot, except ankle

597

1.43

2.58

1.1

1.04

1.06

u/l

0.11

263

Single delivery by caesarean section

404

0.61

2.57

1.1

1.00

1.04

u/l

0.28

153

Sensorineural hearing loss

189

1041

1.27

2.56

1.1

1.11

1.10

u/l

0.05

505

Anomalies of pupillary function

2.75

2.55

1.0

1.1

1.15

1.10

u/l

—

Presbyopia

121

1.99

2.55

1.0

1.1

0.98

1.09

u/l

1.17

All pneumoniae

337

1947

1.20

2.55

1.1

1.14

1.06

u/l

0.98

143

883

Short Achilles tendon (acquired)

2.75

2.55

1.1

0.98

1.11

u/l

—

Menorrhagia

139

578

1.33

2.55

1.1

1.10

1.04

u/l

0.45

236

Memory loss

128

1.96

2.55

1.6

1.0

0.97

1.19

u/l

1.85

Other noninfective gastroenteritis and colitis

507

1.46

2.55

1.1

1.19

1.07

u/l

0.54

226

Brain meningioma, excluding all cancers (controls excluding all cancers)

2.17

2.51

1.1

2.27

1.08

u/l

0.41

Osteoporosis with pathological fracture (FG)

2.28

2.51

1.2

1.1

1.07

1.06

u/l

—

Allergic conjunctivitis

204

1609

1.25

2.50

1.1

0.99

1.06

u/l

1.60

706

Ganglion

428

1.50

2.50

1.1

0.96

1.09

u/l

2.22

192

Monoamine oxidase A inhibitors

194

1.76

2.50

1.1

1.07

1.15

u/l

0.42

Autoimmune hyperthyroidism

2.11

2.48

1.1

1.0

1.23

1.04

u/l

—

Pneumonias (Asthma/COPD co-morbidities)

334

1941

1.19

2.48

1.1

1.14

1.06

u/l

0.98

141

882

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

652

1.40

2.48

1.0

1.1

1.12

1.05

u/l

0.26

297

Undefined dementia

2.34

2.47

1.0

1.38

1.29

u/l

—

Fibroblastic disorders

325

1.57

2.47

1.1

1.05

1.12

u/l

0.65

158

Inflammatory disease of uterus

397

1.52

2.47

1.0

1.1

1.15

1.05

u/l

0.22

164

Other diseases of anus and rectum

511

1.45

2.45

1.1

1.01

1.08

u/l

0.96

244

Emotional disorders starting during childhood or adolecense, excluding more controls

100

2.07

2.45

1.1

1.0

0.92

1.00

u/l

—

Unspecified dementia

2.33

2.45

1.0

1.38

1.25

u/l

—

Perforation of tympanic membrane

203

1.73

2.44

1.1

0.95

1.12

u/l

2.88

Obesity and other hyperalimentation

212

1695

1.24

2.43

1.1

1.19

1.04

u/l

0.44

739

Heartburn

181

1.77

2.43

1.0

0.99

1.13

u/l

1.18

Paralytic ileus

0.00

2.43

0.0

1.1

—

1.24

—

Diseases of middle ear and mastoid

216

1429

1.24

2.42

1.1

1.04

1.02

u/l

0.16

100

610

Thyroiditis

145

1.87

2.41

1.2

1.1

0.94

1.09

u/l

1.43

Poisoning by drugs, medicaments and biological substances

656

1.39

2.41

1.1

1.07

1.04

u/l

0.19

290

Diseases of liver

656

1.39

2.40

1.1

1.09

1.06

u/l

0.17

310

Obesity

211

1690

1.24

2.40

1.1

1.19

1.04

u/l

0.44

736

Hyperlipidaemia, other/unspecified

541

1.42

2.39

1.1

1.06

1.13

u/l

0.38

271

Achilles tendinitis

160

1.82

2.39

1.0

1.1

0.95

1.12

u/l

1.83

Dental caries 3, only avohilmo

271

1140

1.22

2.38

1.1

1.05

1.07

u/l

0.39

114

542

Other viral diseases, not elsewhere classified

432

1.48

2.38

1.1

1.01

1.06

u/l

0.71

197

Chronic conjunctivitis

2.43

2.37

1.1

0.99

1.09

u/l

—

Endometriosis ASRM stages 1,2

491

1.45

2.37

1.0

1.1

0.93

1.05

u/l

2.01

206

Dermatophytosis

220

1.69

2.37

1.1

1.06

1.11

u/l

0.46

120

Benign neoplasm: Skin of lower limb, including hip

2.52

2.36

1.0

1.1

0.92

1.10

u/l

—

Insomnia

402

1.50

2.35

1.1

1.03

1.08

u/l

0.37

178

Supplementary factors related to causes of morbidity and mortality classified elsewhere

693

1.37

2.35

1.1

0.99

1.05

u/l

0.79

306

Other diseases of arteries and capillaries

154

1.82

2.33

1.1

1.14

u/l

0.00

Other noninflammatory disorders of vulva and perineum

206

1.71

2.33

1.1

1.03

1.07

u/l

0.20

Secondary uncertain malignant neoplasm

191

1.73

2.33

1.1

1.28

1.10

u/l

0.36

Weight loss

169

1.78

2.32

1.2

1.0

1.18

1.13

u/l

0.14

Other specified and unspecified retinal disorders

2.32

1.4

1.1

0.97

1.14

u/l

—

Other and unspecified disorders of vitreous body

674

1.37

2.31

1.1

1.03

1.09

u/l

1.25

335

Rosacea

237

1.65

2.31

1.1

0.93

1.12

u/l

3.82

118

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

570

1.39

2.31

1.1

1.08

1.00

u/l

0.39

233

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

536

0.64

2.30

1.1

1.85

1.04

u/l

0.57

257

Obesity due to excess calories

157

1235

1.27

2.29

1.1

1.26

1.04

u/l

0.48

528

Other disorders of patella

429

1.47

2.28

1.0

1.1

1.04

1.07

u/l

0.25

181

Sequelae with surgical and medical care as external cause

340

1.53

2.28

1.1

1.01

1.10

u/l

1.14

169

Venous thromboembolism

129

962

1.30

2.25

1.1

1.05

1.10

u/l

0.54

458

Other disorders of white blood cells

106

1.99

2.25

1.2

1.1

0.98

1.13

u/l

—

Familial hypercholesterolemia

178

1.75

2.25

1.1

1.10

1.13

u/l

0.09

Diseases of tongue

106

1.99

2.25

1.1

1.0

1.19

1.20

u/l

—

N06DA Anticholinesterases

223

1.60

2.25

1.1

1.02

1.15

u/l

1.64

111

Use of anticholinesterases

223

1.60

2.25

1.1

1.02

1.15

u/l

1.64

111

Type of accident

631

1.38

2.24

1.1

1.00

1.05

u/l

0.77

278

Preparation and fitting of bite rail to mouth

334

1.53

2.23

1.1

1.05

1.08

u/l

0.17

151

Abnormal results of function studies

157

1.79

2.21

1.0

1.1

0.94

1.14

u/l

2.40

Unspecified abortion

121

1.91

2.21

1.0

1.10

1.04

u/l

0.18

Methotrexate

248

1.62

2.21

1.1

1.0

1.05

1.10

u/l

0.46

111

Endometriosis diagnosis and infertility diagnosis occurring together

312

1.54

2.18

1.0

1.1

0.87

1.03

u/l

5.15

134

Type 2 diabetes, wide definition

219

1166

1.22

2.18

1.1

1.09

1.10

u/l

0.01

105

562

Haemorrhoids and perianal venous thrombosis

475

1.43

2.17

1.1

1.03

1.09

u/l

0.64

226

Atherosclerosis, excluding cerebral and coronary sclerosis

433

0.61

2.17

1.0

1.1

0.95

1.08

u/l

2.81

216

Injuries to the thorax

117

893

1.31

2.16

1.1

1.00

1.10

u/l

1.18

413

Varicella [chickenpox]

2.03

2.16

1.1

1.26

1.08

u/l

—

Osteonecrosis

101

1.99

2.15

1.0

1.1

1.15

1.19

u/l

—

Other diseases of stomach and duodenum

101

1.99

2.15

1.1

1.0

1.05

1.21

u/l

—

Aplastic and other anaemias

667

1.35

2.15

1.1

1.20

1.05

u/l

0.88

316

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

452

1.44

2.14

1.0

1.1

0.98

1.05

u/l

0.88

182

Other disorders of teeth and supporting structures

395

1.47

2.12

1.0

1.1

1.11

1.07

u/l

0.25

191

Gluteal tendinitis

2.38

2.12

1.2

1.1

1.61

1.20

u/l

—

Persons encountering health services for specific procedures, not carried out

152

1.78

2.11

1.1

1.11

1.07

u/l

—

Other disorders of bone density and structure

2.47

2.11

1.0

1.1

1.04

1.06

u/l

—

Normal-pressure hydrocephalus

2.46

2.10

1.3

1.1

1.17

1.29

u/l

—

Early onset COPD, excluding more controls

283

1.56

2.09

1.1

1.0

0.96

1.17

u/l

1.06

139

Dislocation, sprain and strain of joints and ligaments of knee

214

1636

1.22

2.09

1.1

1.04

1.08

u/l

0.43

720

Parkinson's disease, strict definition

160

1.75

2.09

1.1

1.0

0.96

1.20

u/l

2.96

Other keratitis

252

1.59

2.09

1.0

1.1

1.12

1.11

u/l

0.06

117

Benign neoplasm: Colon, unspecified

322

1.52

2.08

1.1

1.10

1.05

u/l

0.16

150

Fracture at wrist and hand level

108

821

1.32

2.07

1.0

1.1

1.07

1.11

u/l

0.17

370

Asthma mixed form (mode)

2.08

2.06

1.1

1.0

1.07

1.20

u/l

—

Bipolar affective disorders

489

1.41

2.06

1.0

1.1

0.95

1.05

u/l

2.71

212

Early lumbar disc prolapse operation

309

1.53

2.05

1.1

1.05

1.03

u/l

0.17

139

Degeneration of macula and posterior pole

471

1.38

2.05

1.2

1.1

1.08

1.09

u/l

0.06

232

Chronic gastritis

423

1.44

2.05

1.0

1.1

1.20

1.08

u/l

0.30

198

Other predominantly sexually transmitted diseases, not elsewhere classified

549

1.39

2.04

1.1

1.02

1.05

u/l

0.15

221

Lateral epicondylitis

230

1.61

2.04

1.0

1.1

1.11

1.12

u/l

0.08

117

DVT of lower extremities and pulmonary embolism

700

1.34

2.04

1.2

1.1

1.05

1.07

u/l

0.09

329

Use of donepezil

155

1.74

2.03

1.1

0.99

1.18

u/l

2.18

Respiratory disorders in diseases classified elsewhere

3.11

2.02

1.1

1.0

1.11

1.15

u/l

—

Lesion of radial nerve

2.23

2.01

1.0

1.1

1.43

1.08

u/l

—

Asthma mixed form (mode), excluding more controls

2.05

2.01

1.1

1.0

1.07

1.17

u/l

—

Brain meningioma

2.01

2.00

1.1

0.95

1.18

u/l

2.12

Parkinson's disease, including avohilmo

193

1.66

1.99

1.1

0.99

1.16

u/l

2.10

Diseases of external ear

689

1.34

1.98

1.1

0.99

1.06

u/l

1.53

304

Colorectal adenocarcinoma

258

0.46

1.97

1.0

1.1

4.12

1.11

u/l

—

129

Other CVD

240

1.59

1.97

1.2

1.1

1.04

1.13

u/l

0.93

123

Disorders of psychological development

296

1.51

1.97

1.0

1.1

1.20

0.99

u/l

0.87

127

Fracture of rib(s), sternum and thoracic spine

495

1.40

1.94

1.1

1.02

1.07

u/l

0.48

228

Carcinoma in situ of skin of other and unspecified parts of face

2.19

1.94

1.1

1.27

1.15

u/l

—

Adenomyosis (Endometriosis of uterus)

281

1.53

1.94

1.1

1.29

1.06

u/l

0.45

119

Calculus of kidney and ureter

546

1.38

1.94

1.1

1.09

1.06

u/l

0.13

257

Other and unspecified effects of external causes

709

1.33

1.93

1.1

1.03

1.05

u/l

0.15

311

Schizophrenia

399

0.58

1.93

1.0

1.1

1.17

1.07

u/l

—

189

Dental caries 2

277

1847

1.18

1.93

1.1

1.08

1.07

u/l

0.12

115

814

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

226

1.60

1.92

1.1

1.07

1.06

u/l

0.03

102

Secondary polycythaemia

2.58

1.92

1.0

1.1

0.92

1.09

u/l

—

Other and unspecified urticaria

488

1.40

1.92

1.1

1.10

1.06

u/l

0.18

211

Melanocytic naevi

667

1.34

1.92

1.2

1.1

0.97

1.03

u/l

1.13

283

Myocardial infarction, strict

609

0.71

1.91

1.1

1.28

1.12

u/l

0.68

327

Fentanyl

113

1.86

1.91

1.0

1.1

1.15

1.18

u/l

—

Tongue abnormality

106

1.89

1.91

1.2

1.1

1.19

1.16

u/l

—

Sulfasalazine

599

1.35

1.90

1.0

1.25

1.05

u/l

0.63

265

Other disorders of glucose regulation and pancreatic internal secretion

173

1.68

1.89

1.0

1.1

1.07

1.11

u/l

0.15

Unspecific neurodegenerative disorder

271

1.45

1.89

1.1

1.02

1.11

u/l

1.35

138

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

308

1793

1.17

1.88

1.1

1.18

1.05

u/l

0.64

153

799

Fall on same level involving ice and snow

162

1314

1.23

1.88

1.1

1.20

1.07

u/l

0.91

599

Cholecystectomy

197

1439

1.21

1.88

1.1

1.17

1.06

u/l

1.11

642

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

205

1.61

1.85

1.1

1.04

1.06

u/l

0.13

Coronary artery bypass grafting

291

0.57

1.84

1.0

1.1

1.47

1.11

u/l

—

160

Parkinson's disease

182

1.65

1.84

1.1

1.0

0.99

1.16

u/l

1.95

Poisoning by medicine

603

1.35

1.84

1.1

1.06

1.04

u/l

0.15

270

Intermittent heterotropia

122

1.81

1.84

1.0

1.09

1.03

u/l

—

Hypotension

190

1.63

1.83

1.3

1.1

1.07

1.16

u/l

0.69

Elevated blood glucose level

152

1.72

1.83

1.1

0.94

1.16

u/l

2.76

Substance abuse, excluding more controls

154

1089

1.24

1.83

1.1

1.09

1.10

u/l

0.04

508

Inflammatory diseases of prostate (prostatitis)

183

1.64

1.81

1.0

1.1

0.94

1.03

u/l

0.99

Injuries to the elbow and forearm

209

1577

1.20

1.81

1.0

1.1

1.05

1.07

u/l

0.18

707

Other pleural conditions

123

1.79

1.0

1.1

0.91

1.22

u/l

4.18

Benign neoplasm: Skin of lower limb, including hip

2.18

1.78

1.0

1.1

0.92

1.09

u/l

—

Hodgkin lymphoma, hilmo

2.18

1.78

1.2

1.0

1.28

1.05

u/l

—

Malignant neoplasm of digestive organs

504

0.64

1.78

1.1

2.08

1.09

u/l

0.52

251

Cardiodefibrillation

523

0.65

1.78

1.0

1.1

0.93

1.08

u/l

3.09

255

Bleeding

213

1295

1.20

1.77

1.1

1.07

1.09

u/l

0.16

619

Nonspecific lymphadenitis

131

1.76

1.77

1.2

1.1

1.03

1.04

u/l

0.09

Other/unspecified enthesopathies, not elsewhere classified

131

1.76

1.77

1.0

1.1

1.08

1.17

u/l

0.36

Type 1 diabetes, strict definition

259

0.50

1.77

1.2

1.1

0.85

1.00

u/l

—

106

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

2.10

1.76

1.0

1.1

1.08

1.07

u/l

—

Impingement syndrome of shoulder

395

1.42

1.76

1.0

1.1

0.97

1.18

u/l

1.76

204

Noninfective enteritis and colitis

141

1135

1.24

1.76

1.1

1.09

1.05

u/l

0.27

497

Antenatal screening

477

0.72

1.75

1.0

1.1

0.99

1.06

u/l

0.79

186

Amblyopia ex anopsia

2.04

1.75

1.0

1.00

1.03

u/l

—

Fracture of forearm

153

1166

1.23

1.73

1.0

1.1

1.07

1.06

u/l

0.07

529

Other and unspecified drugs and medicaments

170

1.65

1.73

1.1

1.09

1.14

u/l

—

Adverse effects, not elsewhere classified

498

1.37

1.73

1.1

1.04

1.07

u/l

0.14

213

Hyperplasia of prostate

319

1.36

1.72

1.1

1.06

1.16

u/l

0.50

169

Other condition

282

1.49

1.71

1.1

1.01

1.09

u/l

0.68

137

Other benign neoplasm of uterus: Other parts/unspecified

0.00

1.70

0.0

1.0

—

1.34

—

Gingivitis and periodontal diseases

290

1285

1.17

1.69

1.1

1.08

1.09

u/l

0.08

125

587

Dental caries 2 and operation codes

271

1848

1.17

1.69

1.1

1.08

1.07

u/l

0.09

111

814

All-cause Heart Failure

645

0.74

1.69

1.1

1.19

1.06

u/l

0.61

319

Tobacco use

126

1.75

1.68

1.1

0.95

1.09

u/l

1.21

Injury of muscle and tendon at shoulder and upper arm level

630

1.32

1.68

1.1

1.09

1.13

u/l

0.20

313

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

203

1.58

1.68

1.0

1.1

1.02

1.07

u/l

0.31

Other and unspecified tonsillitis

134

915

1.24

1.67

1.1

0.99

1.09

u/l

1.32

402

Other disorders of conjunctiva

219

1.56

1.67

1.1

1.27

1.13

u/l

0.25

115

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

200

1368

1.19

1.66

1.0

1.1

1.03

1.06

u/l

0.46

578

Myocardial infarction

648

0.74

1.65

1.1

1.22

1.12

u/l

0.46

349

Disturbance of activity and attention

297

1.47

1.65

1.0

1.1

0.94

0.98

u/l

0.28

121

Recurrent dislocation of patella

150

1.67

1.63

1.1

1.00

1.01

u/l

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

103

804

1.27

1.62

1.1

1.00

1.04

u/l

0.32

352

Urolithiasis

582

1.32

1.61

1.1

1.08

1.06

u/l

0.13

278

Burns and corrosions confined to eye and internal organs

2.16

1.61

1.0

1.1

0.99

1.08

u/l

—

Type 1 diabetes, strict definition, subgroup 1

250

0.52

1.61

1.2

1.1

0.85

1.00

u/l

—

101

Heart failure, strict

655

0.75

1.61

1.1

1.19

1.05

u/l

0.66

326

Other disorders of penis

143

1.68

1.60

1.1

0.99

1.04

u/l

0.29

Cardiomyopathy, other and unspecified

128

1.72

1.60

1.2

1.1

1.04

1.15

u/l

0.65

Other and unspecified vascular occlusions

113

1.77

1.60

1.3

1.0

0.99

1.23

u/l

—

Separation of retinal layers (serosa)

1.91

1.60

1.1

0.95

1.12

u/l

—

Other bursopathies

182

1.60

1.0

1.1

0.97

1.15

u/l

2.07

Noninfectious colitis NAS

287

1.47

1.59

1.1

1.11

1.10

u/l

0.02

136

Fall on and from stairs and steps

515

1.34

1.58

1.0

1.1

1.12

1.07

u/l

0.15

234

Other disorders of cornea

175

1.60

1.57

1.0

1.1

1.09

1.13

u/l

0.13

Medicines for HER+ breast cancer

667

0.71

1.57

1.0

1.1

1.00

1.10

u/l

1.12

314

Other inflammation of eyelid

247

1.50

1.57

1.3

1.0

1.05

1.12

u/l

0.37

121

Later onset COPD

226

0.56

1.56

1.1

1.08

1.11

u/l

—

117

Trigger finger

215

1.54

1.56

1.1

1.06

1.13

u/l

0.51

109

Deposits [accretions] on teeth

110

1.76

1.56

1.1

0.96

1.11

u/l

1.79

Injury of nerves at wrist and hand level

1.89

1.55

1.1

1.0

1.08

u/l

—

Benign neoplasm: Rectum, anus and anal canal

264

1.48

1.55

1.2

1.1

1.03

1.06

u/l

0.18

119

Superficial injury of lower leg

569

1.32

1.55

1.1

0.97

1.05

u/l

1.39

246

Ménière disease

168

1.61

1.55

1.0

1.01

1.10

u/l

0.83

Mixed and other personality disorders

216

1.53

1.54

1.1

1.04

1.05

u/l

0.03

101

Rheumatoid arthritis, including avohilmo

754

1.27

1.53

1.1

1.22

1.07

u/l

0.71

349

Anankastic personality disorder

100

1.81

1.53

1.0

1.1

1.02

1.03

u/l

—

Diseases of male genital organs

143

588

1.23

1.53

1.1

1.03

1.11

u/l

0.67

288

Diaphragmatic hernia

649

1.30

1.52

1.1

1.01

1.07

u/l

0.93

318

Dental caries 2, only avohilmo

270

1845

1.15

1.52

1.1

1.09

1.07

u/l

0.16

113

811

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

0.00

1.52

0.0

1.1

—

1.15

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

1.52

0.0

1.1

—

1.19

—

Noninflammatory disorders of female genital tract

172

718

1.21

1.52

1.1

1.12

1.03

u/l

0.78

298

KRA_PSY_EATING, excluding more controls

216

1.53

1.51

1.0

1.1

1.11

1.04

u/l

—

Other diseases of oesophagus

138

1.67

1.51

1.0

1.1

1.05

1.15

u/l

0.75

Other gastritis (incl. Duodenitis)

374

1.39

1.51

1.2

1.1

1.27

1.07

u/l

1.03

180

Burn and corrosion confined to eye and adnexa

2.17

1.51

1.0

1.1

1.00

1.08

u/l

—

Pruritus

209

1.53

1.51

1.1

1.05

1.14

u/l

0.31

Seronegative rheumatoid arthritis

193

1.56

1.50

1.0

1.1

1.21

1.07

u/l

0.34

Retinal detachment with retinal break

193

1.56

1.50

1.1

1.07

1.14

u/l

0.28

105

Renal tubulo-interstitial diseases

255

1689

1.16

1.50

1.1

1.10

1.07

u/l

0.20

101

763

Other epidermal thickening

1.91

1.49

1.1

1.0

0.94

1.08

u/l

—

False labour

137

702

1.23

1.49

1.1

0.98

1.04

u/l

0.79

270

Reactive arthropathies, FINNGEN

131

1.68

1.49

1.0

1.1

0.91

1.07

u/l

—

Use of rivastigmine

108

1.76

1.49

1.1

1.04

1.23

u/l

—

Other sexually transmitted chlamydial diseases

218

1.52

1.48

1.0

1.1

1.00

u/l

—

Anogenital herpesviral [herpes simplex] infection

178

1.58

1.48

1.1

0.96

1.04

u/l

1.23

Melanocytic naevi

696

1.28

1.48

1.2

1.1

0.97

1.06

u/l

1.89

306

Hypertrophic disorders of skin

139

1.66

1.48

1.1

1.03

1.07

u/l

0.21

Bacterial intestinal infections, IBD co-morbidities

300

1.44

1.48

1.2

1.1

1.03

1.11

u/l

0.64

146

Misadventures to patients during surgical and medical care

259

1.47

1.1

1.11

1.12

u/l

0.03

123

Suicide or other Intentional self-harm

653

1.29

1.47

1.1

1.09

1.05

u/l

0.33

292

Personal history of certain other diseases

2.24

1.47

1.0

1.1

1.06

1.07

u/l

—

Maternal care for known or suspected malpresentation of fetus

522

0.73

1.46

1.2

1.1

1.01

u/l

0.02

205

Ankylosing spondylitis, ICD10

211

1.52

1.45

1.1

1.46

1.07

u/l

0.59

105

Radial styloid tenosynovitis [de Quervain]

102

1.77

1.44

1.0

1.1

1.00

1.15

u/l

—

Ovarian dysfunction

244

1.48

1.44

1.0

1.1

1.07

1.00

u/l

0.29

Erosion of teeth

3.14

1.44

1.0

1.1

—

1.14

—

Degenerative macular diseases

148

1.62

1.44

1.1

1.07

1.17

u/l

0.50

Urethral stricture

1.92

1.43

1.0

1.09

1.14

u/l

—

Other blood glucose lowering drugs, excl. Insulins

236

1.49

1.43

1.1

1.17

1.10

u/l

0.48

117

Congenital malformations of ovaries, fallopian tubes and broad ligaments

156

1.61

1.43

1.0

1.1

1.25

1.06

u/l

0.24

Disorders of parathyroid gland

290

1.43

1.1

1.24

1.10

u/l

0.31

143

Other disorders of adrenal gland

1.80

1.43

1.4

1.1

1.15

1.06

u/l

0.30

Benign neoplasm: Choroid

1.80

1.43

1.2

1.1

1.03

1.09

u/l

—

Type1 diabetes, definitions combined, early onset

213

0.51

1.43

1.2

1.1

0.84

1.01

u/l

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

227

0.53

1.43

1.0

1.1

4.12

1.05

u/l

—

104

Benign neoplasm: Colon, unspecified

353

1.39

1.42

1.1

1.10

u/l

0.01

172

Colorectal cancer

303

0.59

1.42

1.1

2.62

1.09

u/l

—

150

Nutritional anaemias

112

881

1.24

1.41

1.0

1.1

1.52

1.06

u/l

0.73

401

Other diseases of blood and blood-forming organs

118

1.70

1.41

1.2

1.1

0.99

1.19

u/l

1.78

Benign neoplasm: Rectum

229

1.49

1.41

1.2

1.1

1.03

1.06

u/l

0.18

102

Other diseases of liver

354

1.39

1.41

1.1

1.16

1.09

u/l

0.23

171

Fracture of lower leg, including ankle

150

1247

1.20

1.39

1.1

1.09

u/l

0.02

564

Lung diseases due to external agents

181

1.55

1.39

1.1

1.12

1.15

u/l

0.09

Ankylosing spondylitis, strict definition

111

1.72

1.39

1.0

1.1

1.70

1.05

u/l

—

Oligomenorrhoea

1.78

1.39

1.2

1.1

1.33

1.03

u/l

—

Carcinoma in situ of skin of other and unspecified parts of face

1.90

1.39

1.1

1.27

1.26

u/l

—

Benign neoplasm: Transverse colon

134

1.65

1.39

1.1

0.94

1.10

u/l

2.32

Malignant melanoma, excluding all cancers (controls excluding all cancers)

238

1.47

1.39

1.1

1.03

1.06

u/l

0.20

106

Hodgkin lymphoma

1.95

1.38

1.2

1.0

1.28

1.00

u/l

—

Torsion of ovary, ovarian pedicle and fallopian tube

2.01

1.38

1.1

0.96

1.05

u/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

142

1.62

1.38

1.0

1.1

1.10

1.06

u/l

—

Deep endometriosis

239

1.47

1.36

1.0

1.1

0.97

1.10

u/l

1.01

106

Car occupant injured in other and unspecified transport accidents

494

1.32

1.36

1.0

1.1

0.98

1.06

u/l

1.21

223

Other abnormal findings of blood chemistry

1.84

1.35

1.1

0.97

1.07

u/l

—

Other maternal disorders predominantly related to pregnancy

212

1144

1.17

1.35

1.1

1.02

1.07

u/l

0.89

469

Benign neoplasm: Ascending colon

175

1.55

1.34

1.1

1.09

1.07

u/l

0.05

Bicipital tendinitis

1.92

1.33

1.0

1.00

1.17

u/l

—

Unspecified haematuria

575

1.27

1.32

1.1

1.07

u/l

0.06

274

Recurrent dislocation and subluxation of joint

176

1.54

1.31

1.0

1.1

1.05

1.06

u/l

0.08

Other and unspecified acute skin changes due to ultraviolet radiation

0.00

1.31

0.0

1.0

—

1.10

—

Disorder of lipoprotein metabolism, unspecified

168

1.55

1.31

1.1

1.19

1.14

u/l

0.11

Papulosquamous disorders

104

844

1.23

1.30

1.1

0.98

1.07

u/l

1.22

390

Chondropathies

360

1.36

1.29

1.0

1.1

1.01

1.09

u/l

0.96

170

L02BG Aromatase inhibitors

521

0.71

1.29

1.1

0.99

1.11

u/l

1.16

252

Mental disorders, not otherwise specified

234

1.46

1.29

1.1

1.14

1.04

u/l

0.51

107

Correction of physiology of bite - demanding therapy visit

169

1.54

1.28

1.1

0.94

1.05

u/l

1.52

COPD, hospital admissions 1, only main diagnosis

404

0.69

1.28

1.1

0.93

1.09

u/l

3.46

193

Infections of genitourinary tract in pregnancy

276

1.42

1.28

1.1

0.94

1.06

u/l

2.59

105

Malignant neoplasm of breast, HER-negative

354

0.65

1.28

1.0

1.1

1.27

1.08

u/l

0.42

166

Viral conjunctivitis

2.01

1.27

1.0

1.1

0.88

1.08

u/l

—

Postprocedural disorders of digestive system, not elsewhere classified

2.01

1.27

1.0

1.04

1.09

u/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

544

1.29

1.27

1.0

1.1

1.00

1.06

u/l

0.61

252

Emotional disorders and disorders of social functioning with onset specific to childhood

136

1.60

1.26

1.1

1.0

0.92

0.98

u/l

—

Emotional disorders starting during childhood or adolescence

129

1.62

1.26

1.1

0.92

1.00

u/l

—

Hyperkinetic disorders

315

1.38

1.26

1.0

1.1

0.94

0.99

u/l

0.35

130

Hypoglycaemia, other or unspecified

138

1.60

1.26

1.0

1.1

1.09

1.07

u/l

0.06

Other and unspecified injuries of lower leg

162

1.55

1.25

1.0

1.07

u/l

—

Stomatitis and related lesions

162

1.55

1.25

1.0

1.1

1.19

1.14

u/l

—

Polycystic ovarian syndrome, consortium definition

251

1325

1.14

1.25

1.1

1.03

1.05

u/l

0.23

113

555

Gastric ulcer

244

1.44

1.25

1.1

1.02

1.09

u/l

0.46

124

Overexertion and strenuous or repetitive movements

228

1.45

1.24

1.0

1.1

1.09

1.12

u/l

—

112

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

476

1.30

1.24

1.1

1.07

1.04

u/l

0.17

206

Perineal laceration during delivery

542

0.74

1.23

1.0

1.1

1.20

0.98

u/l

1.11

200

Abnormal findings on antenatal screening of mother

287

1.40

1.23

1.0

1.1

1.01

1.03

u/l

0.13

100

Event of undetermined intent

147

1.57

1.23

1.1

1.06

1.04

u/l

—

Abnormal serum enzyme levels

453

1.31

1.22

1.1

1.09

1.08

u/l

0.03

229

Neovascular glaucoma

1.97

1.22

1.3

1.1

1.06

1.12

u/l

—

Presence of other devices

304

1.38

1.22

1.1

1.10

1.11

u/l

0.02

140

Septal defects

121

1.62

1.21

1.0

1.1

1.00

1.03

u/l

—

Open wound of wrist and hand

131

1088

1.19

1.20

1.1

1.00

1.09

u/l

1.18

503

Other specified and unspecified personality disorders

238

1.43

1.20

1.1

0.98

1.06

u/l

0.85

110

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

148

1.56

1.20

1.0

1.1

1.10

1.14

u/l

—

Congenital malformations and deformations of the musculoskeletal system

212

1.46

1.20

1.1

0.93

1.04

u/l

2.29

Obesity, other/unspecified

107

881

1.22

1.19

1.1

1.04

1.06

u/l

0.25

368

Other and unspecified iridocyclitis

1.75

1.19

1.3

1.1

1.13

1.05

u/l

—

Alzheimer’s disease, wide definition

164

1.48

1.18

1.2

1.1

1.01

1.19

u/l

2.48

Malignant neoplasm of breast, HER-positive

606

0.75

1.18

1.0

1.1

1.00

1.11

u/l

1.28

286

Heart failure,strict

616

0.78

1.18

1.1

1.20

1.05

u/l

0.74

302

Other and unspecified rosacea

173

1.51

1.17

1.1

0.90

1.14

u/l

—

Benign neoplasm of major salivary glands

157

1.53

1.17

1.1

1.01

1.09

u/l

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

378

0.69

1.16

1.0

1.1

1.22

1.08

u/l

0.36

179

Benign neoplasm: Choroid

102

1.67

1.16

1.2

1.1

1.03

1.19

u/l

—

Other embolism and thrombosis

223

1.44

1.16

1.0

1.1

0.99

1.12

u/l

1.49

114

Amputation of foot

0.00

1.16

0.0

1.0

—

1.08

—

Fall involving bed

0.00

1.16

0.0

1.0

—

1.12

—

Diabetic retinopathy, excluding more controls

258

1.31

1.16

1.1

1.16

1.06

u/l

0.27

131

Benign neoplasm of other and ill-defined parts of digestive system

265

1.40

1.16

1.2

1.1

1.09

1.05

u/l

0.30

118

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

164

1230

1.17

1.16

1.0

1.1

1.03

1.07

u/l

0.43

518

Otitis externa

490

1.29

1.16

1.0

1.1

0.99

1.08

u/l

1.31

223

Heart failure and coronary heart disease

285

0.68

1.15

1.0

1.1

1.45

1.10

u/l

—

146

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.00

1.15

0.0

1.1

—

1.08

—

Oesophagitis

1.73

1.15

1.1

1.0

0.98

1.19

u/l

—

Adjustment and management of implanted device

207

1.45

1.14

1.1

1.01

1.08

u/l

0.48

Paralytic ileus and intestinal obstruction

403

1.32

1.14

1.1

0.98

1.09

u/l

1.25

192

Hypertrophic scar

126

1.59

1.14

1.1

0.98

1.08

u/l

—

HSIL lesion of the vagina

0.00

1.14

0.0

1.1

—

1.13

—

Other bacterial intestinal infections

317

1.36

1.14

1.2

1.1

1.06

1.09

u/l

0.15

151

Dental caries 2 and operation codes, only avohilmo

237

1293

1.14

1.13

1.1

1.10

1.03

u/l

0.69

555

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

496

0.75

1.13

1.0

1.1

1.00

1.08

u/l

0.84

224

Pregnancy hypertension

153

1179

1.17

1.13

1.0

1.1

1.00

1.05

u/l

1.00

490

Premature rupture of membranes

590

0.78

1.12

1.1

0.94

1.01

u/l

1.49

237

Other disorders of the genitourinary system

208

1.44

1.12

1.0

1.1

1.04

1.10

u/l

0.44

Use of memantine

166

1.47

1.12

1.0

1.1

1.08

1.17

u/l

0.49

Use of other anti-dementia drugs

166

1.47

1.12

1.0

1.1

1.08

1.17

u/l

0.49

Disorders of breast

150

1188

1.17

1.12

1.1

1.06

1.07

u/l

0.06

505

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

285

1653

1.12

1.0

1.1

1.10

1.08

u/l

0.18

126

759

Dental operations

191

848

1.16

1.12

1.1

1.05

1.12

u/l

0.67

410

Diseases of the digestive system

102

842

1.21

1.10

1.1

1.04

1.05

u/l

0.10

384

Type 1 diabetes, definitions combined

304

0.65

1.09

1.2

1.1

0.88

1.02

u/l

—

131

Type 1 diabetes, strict (exclude DM2)

304

0.65

1.09

1.2

1.1

0.88

1.01

u/l

—

130

Atopic dermatitis

198

1476

1.15

1.09

1.1

0.97

1.04

u/l

3.22

645

Cholecystitis

201

1.44

1.09

1.1

1.20

1.09

u/l

0.29

105

Diabetic retinopathy

332

1.28

1.09

1.1

1.14

1.05

u/l

0.31

163

Sulfonylureas

384

0.73

1.08

1.0

1.1

1.09

1.08

u/l

0.05

196

L02BA Anti-estrogens

304

0.66

1.08

1.1

1.01

1.11

u/l

0.60

143

Other and unspecified iron deficiency

575

1.25

1.08

1.0

1.1

1.26

1.07

u/l

0.57

259

conjunctival haemorrhage

120

1.59

1.08

1.2

1.1

1.38

1.18

u/l

—

Tuberculosis, IBD comorbidity

1.69

1.07

1.1

1.06

1.25

u/l

—

Iron deficiency anaemia

758

1.22

1.07

1.0

1.1

1.57

1.05

u/l

0.73

343

Superficial injury of neck

1.94

1.06

1.1

0.98

1.07

u/l

—

Speech therapy

497

1.27

1.06

1.1

1.05

1.08

u/l

0.23

232

Leiomyoma of uterus

157

759

1.17

1.05

1.1

1.02

1.06

u/l

0.61

313

Insulin, combination of fast acting with intermediate-acting or long-acting

155

1232

1.16

1.05

1.1

1.14

1.08

u/l

0.39

578

Infectious mononucleosis

271

1.37

1.04

1.1

0.90

0.99

u/l

1.66

117

Budesonide

271

1.37

1.04

1.2

1.0

1.05

1.08

u/l

0.15

121

Excessive, frequent and irregular menstruation

146

694

1.17

1.04

1.1

1.06

1.03

u/l

0.25

287

Gonarthrosis, primary, with knee surgery

746

0.81

1.03

1.1

1.03

1.09

u/l

0.94

370

Dermatitis due to ingested food

1.75

1.03

1.2

1.0

0.86

1.02

u/l

—

Schizophrenia or delusion, excluding more controls

664

1.23

1.03

1.0

1.1

0.99

1.06

u/l

0.71

294

Suppurative and unspecified otitis media

134

1014

1.17

1.03

1.1

1.07

1.03

u/l

0.23

416

Congenital malformations of genital organs

253

1.38

1.03

1.1

1.20

1.03

u/l

0.33

109

Glaucoma secondary to other eye disorders

1.84

1.03

1.3

1.0

1.06

1.24

u/l

—

Other neurotic disorders

1.74

1.02

1.1

0.93

1.13

u/l

—

Benign neoplasm: Parotid gland

130

1.54

1.02

1.1

1.01

1.07

u/l

—

Congenital malformations of the circulatory system

305

1.34

1.02

1.0

1.1

1.01

1.08

u/l

0.51

149

Haemorrhage from respiratory passages

505

1.25

1.01

1.1

1.02

1.05

u/l

0.30

234

Keratoconus

1.90

1.01

1.0

1.1

1.14

1.10

u/l

—

Fitting and adjustment of other devices

440

1.27

1.01

1.1

0.99

1.06

u/l

1.19

201

Colectomy operation

275

0.65

1.01

1.1

1.05

1.10

u/l

—

140

Endometriosis ASRM stages 3,4

590

1.24

1.01

1.1

0.93

1.05

u/l

2.59

246

Prolonged pregnancy

515

0.76

1.01

1.0

1.1

0.90

1.01

u/l

—

201

Atrial fibrillation and flutter

412

1.24

1.01

1.1

0.98

1.14

u/l

1.18

212

Disorders of gallbladder, biliary tract and pancreas

288

1667

1.11

1.00

1.1

1.13

1.08

u/l

0.59

123

751

Impotence

1.77

1.00

1.2

1.1

1.17

1.12

u/l

—

Benign neoplasm: Transverse colon

147

1.50

1.00

1.1

0.94

1.18

u/l

3.07

Salpingitis and oophoritis

395

1.29

1.00

1.0

1.1

1.08

1.10

u/l

0.06

190

Female infertility, cervigal, vaginal, other or unspecified origin

109

612

1.19

1.00

1.1

1.04

1.03

u/l

0.07

251

Acute suppurative otitis media

100

780

1.20

1.00

1.1

1.10

1.03

u/l

0.28

319

Atrial fibrillation and flutter with reimbursement

285

1.28

0.99

1.1

0.99

1.17

u/l

1.02

166

Other infectious diseases

131

1.53

0.99

1.2

1.1

1.05

1.17

u/l

—

Arthrosis

210

1017

1.14

0.99

1.1

1.07

1.10

u/l

0.17

461

Rheumatoid arthritis

578

1.23

0.99

1.1

1.27

1.05

u/l

0.94

268

Benign neoplasm: Ascending colon

189

1.43

0.98

1.1

1.09

1.14

u/l

0.13

Assault

361

1.30

0.98

1.1

1.06

1.04

u/l

0.26

163

Alzheimer disease, including avohilmo

215

1.34

0.98

1.1

0.99

1.16

u/l

2.72

111

Otitis media, unspecified

260

1.35

0.98

1.0

1.1

0.98

1.03

u/l

0.69

112

Universal erythroderma, KELA reimbursement

0.00

0.98

0.0

1.1

—

1.07

—

Evidence of alcohol involvement determined by blood alcohol level

0.00

0.98

0.0

1.0

—

1.05

—

Respiratory conditions due to other external agents

0.00

0.97

0.0

1.0

—

1.12

—

Vitreous haemorrhage

173

1.45

0.97

1.0

1.1

0.98

1.14

u/l

—

Contact with sharp glass

1.64

0.97

1.2

1.1

0.94

1.06

u/l

—

Tuberculosis, wide

1.63

0.97

1.1

1.06

1.25

u/l

—

Allergic urticaria

190

1.42

0.96

1.1

1.50

1.12

u/l

—

Pneumonitis due to solids and liquids

100

1.60

0.96

1.1

1.0

1.10

1.14

u/l

0.12

Adenocarcinoma and papillary adenocarcinoma of stomach

0.00

0.96

0.0

1.0

—

1.11

—

Benign neoplasm: Sigmoid colon

241

1.37

0.96

1.2

1.1

1.68

1.06

u/l

0.47

105

Other eating disorders

157

1.47

0.96

1.0

0.93

1.02

u/l

—

Follicular cysts of skin and subcutaneous tissue

389

1.29

0.96

1.1

1.05

1.08

u/l

0.14

183

Nonsuppurative otitis media

584

1.21

0.94

1.1

0.98

1.04

u/l

0.96

250

Cholelithiasis, broad definition with cholecystitis

245

1502

1.12

0.94

1.1

1.14

1.07

u/l

0.64

108

675

Type 2 diabetes

310

1666

1.11

0.94

1.1

1.08

1.09

u/l

0.10

148

745

Benign neoplasm of bone and articular cartilage

166

1.45

0.94

1.0

1.1

0.88

1.07

u/l

—

Crushed, pushed or stepped on by crowd or human stampede

183

1.42

0.93

1.1

0.95

1.04

u/l

—

Thyrotoxicosis with diffuse goitre

303

1.32

0.93

1.1

1.0

1.16

1.07

u/l

0.41

137

Alzheimer disease

188

1.36

0.93

1.1

0.99

1.17

u/l

2.69

101

Dialysis, with operation codes

217

1.38

0.93

1.2

1.1

0.98

1.12

u/l

1.50

118

Parodontitis or/and operation codes

165

1119

0.88

0.91

1.1

1.03

1.05

u/l

0.33

477

Agoraphobia

1.67

0.91

1.2

1.0

0.90

1.07

u/l

—

Reactive arthropathies

184

1.42

0.91

1.1

0.96

1.09

u/l

1.52

Childhood asthma (age<16), excluding more controls

317

1.28

0.91

1.1

0.91

1.03

u/l

1.62

127

Sudden idiopathic hearing loss

176

1.42

0.90

1.1

1.01

1.12

u/l

0.57

Lichen planus

210

1.38

0.90

1.1

1.15

1.13

u/l

0.05

111

Distal bite

1.66

0.89

1.0

1.1

0.93

1.02

u/l

—

Cellulitis

438

1.26

0.89

1.1

0.95

1.08

u/l

3.24

195

Olecranon bursitis

1.69

0.88

1.3

1.0

1.20

1.16

u/l

—

Cutaneous abscess, furuncle and carbuncle

601

1.22

0.88

1.1

1.01

1.06

u/l

0.29

267

Childhood asthma (age<16)

319

1.27

0.88

1.1

0.91

1.03

u/l

1.58

128

Cardiac arrest

1.70

0.87

1.0

1.1

0.98

1.19

u/l

—

Injuries to the hip and thigh

100

776

1.18

0.87

1.1

1.03

1.05

u/l

0.18

356

Benign neoplasm: Rectum, anus and anal canal

298

1.31

0.87

1.2

1.1

1.03

1.12

u/l

0.71

143

Specific development disorders of scholastic skills

102

1.56

0.86

1.1

0.93

0.98

u/l

—

Gestational [pregnancy-induced] hypertension

830

1.18

0.86

1.0

1.1

0.99

1.03

u/l

0.57

342

Diseases of peritoneum

161

1.43

0.86

1.0

1.1

1.02

1.13

u/l

0.81

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.72

0.86

1.4

1.0

1.00

1.15

u/l

—

Unspecified privation

212

1.37

0.86

1.1

1.02

1.12

u/l

—

107

Coronary revascularization (ANGIO or CABG)

562

0.82

0.86

1.0

1.1

1.15

1.12

u/l

0.08

303

Ventral hernia

425

0.75

0.85

1.1

1.06

1.07

u/l

0.03

197

Bronchitis, not specified as acute or chronic

153

1.44

0.85

1.0

1.1

0.96

1.16

u/l

—

Other appendicitis

170

1.41

0.85

1.0

1.1

0.86

1.14

u/l

—

Other maltreatment syndromes

1.60

0.84

1.1

1.0

1.07

1.03

u/l

—

Benign lipomatous neoplasm

550

1.22

0.84

1.1

1.13

1.04

u/l

0.30

237

Generalized epilepsy

1.57

0.84

1.0

1.1

0.92

1.06

u/l

—

Medical abortion

216

1050

1.12

0.84

1.1

1.05

1.06

u/l

0.04

449

177

1.39

0.84

1.2

1.1

1.19

1.16

u/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

478

1.24

0.84

1.0

1.1

1.02

1.06

u/l

0.45

236

Atopic dermatitis, strict definition

105

881

1.17

0.84

1.1

0.96

1.04

u/l

1.94

368

Lichen sclerosus et atrophicus

179

1.40

0.84

1.3

1.1

1.16

1.10

u/l

—

Multiple myeloma and malignant plasma cell neoplasms

1.76

0.83

1.3

1.1

1.04

1.17

u/l

—

Multiple myeloma and malignant plasma cell neoplasms

1.76

0.83

1.3

1.1

1.04

1.12

u/l

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

1.76

0.83

1.3

1.1

1.04

1.12

u/l

—

Coronary atherosclerosis

114

853

0.86

0.83

1.1

1.06

1.11

u/l

0.43

451

Myocardial infarction, unclassifiable

213

0.67

0.83

1.0

1.1

1.07

1.15

u/l

—

103

Amenorrhoea

205

1.37

0.83

1.2

1.1

1.01

0.99

u/l

0.14

Gestational diabetes (for exclusion)

154

958

1.14

0.83

1.1

0.99

1.02

u/l

0.38

358

Polyarthrosis

288

1.30

0.83

1.1

1.05

1.10

u/l

0.33

142

Allergic rhinitis

105

892

1.17

0.82

1.1

1.00

1.05

u/l

0.60

387

Congenital malformations of cardiac septa

133

1.46

0.82

1.0

1.1

1.00

1.03

u/l

—

Lichen simplex chronicus and prurigo

113

1.51

0.82

1.1

0.90

1.17

u/l

—

Nail disorders

180

1.39

0.81

1.0

1.1

1.04

1.09

u/l

0.32

Major coronary heart disease event excluding revascularizations

101

814

0.86

0.81

1.1

1.18

1.10

u/l

0.54

419

Other and unspecified injuries of ankle and foot

1.55

0.81

1.0

1.1

0.92

1.05

u/l

—

Candidiasis

293

1.30

0.81

1.1

1.11

1.10

u/l

0.01

138

Sequelae of injuries of upper limb

206

1.36

0.81

1.0

1.1

1.09

1.12

u/l

0.13

107

Vasomotor rhinitis (mode)

155

1.42

0.81

1.1

0.93

1.10

u/l

2.63

Other/unspecified synovitis and tenosynovitis

189

1.38

0.80

1.1

1.16

1.14

u/l

—

Gonarthrosis [arthrosis of knee](FG)

187

980

1.12

0.80

1.1

1.05

1.10

u/l

0.53

461

Hernia of abdominal wall

937

0.84

0.80

1.1

1.06

1.10

u/l

0.24

440

Pedal cyclist injured in noncollision transport accidents

250

1.32

0.80

1.0

1.1

1.12

1.11

u/l

0.03

123

DVT of lower extremities

285

1.30

0.79

1.1

1.01

1.10

u/l

1.08

138

Erosion of teeth, including avohilmo

500

1.22

0.79

1.0

1.1

1.19

1.02

u/l

0.48

207

Malignant neoplasm of other and unspecified female genital organs

0.00

0.79

0.0

1.0

—

1.17

—

Portal vein thrombosis

0.00

0.79

0.0

1.0

—

1.06

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.0

—

1.05

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

738

1.18

0.79

1.1

1.07

1.05

u/l

0.11

334

Benign neoplasm: Parotid gland

139

1.44

0.79

1.1

1.01

1.17

u/l

—

Nummular dermatitis

139

1.44

0.79

1.1

1.23

1.16

u/l

—

Female genital prolapse

418

1.19

0.79

1.0

1.1

1.01

1.06

u/l

0.52

181

Sequelae of other external causes

106

1.51

0.79

1.1

1.36

1.15

u/l

—

Colitis, primary sclerosing

0.00

0.78

0.0

1.1

—

1.07

—

Carcinoma in situ of skin of lower limb, including hip

0.00

0.78

0.0

1.0

—

1.05

—

Carcinoma in situ of skin of lower limb, including hip

0.00

0.78

0.0

1.1

—

1.17

—

Cardiomyopathy

277

1.30

0.78

1.1

1.01

1.08

u/l

0.58

147

Colorectal cancer, excluding all cancers (controls excluding all cancers)

361

0.75

0.78

1.0

1.1

2.25

1.05

u/l

0.47

166

Complications of labour and delivery

176

1101

0.89

0.78

1.1

1.04

1.05

u/l

0.14

458

Diverticular disease of intestine

158

928

1.13

0.78

1.1

0.99

1.12

u/l

2.58

468

Schizoaffective disorder

199

0.65

0.78

1.0

1.1

1.00

1.05

u/l

—

Atopic dermatitis, strict definition with reimbursement

108

905

1.16

0.78

1.1

0.96

1.04

u/l

1.85

380

Polycystic ovarian syndrome

182

1.38

0.78

1.0

1.06

1.00

u/l

0.18

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

0.77

0.0

1.0

—

0.99

—

Outcome of delivery

382

1.20

0.77

1.0

1.1

1.04

1.03

u/l

0.07

149

Assault by bodily force

208

1.35

0.77

1.1

1.06

1.05

u/l

0.10

104

Pre-eclampsia or poor fetal growth

114

988

1.15

0.77

1.0

1.1

1.00

1.04

u/l

0.50

409

Other menopausal disorders

387

1.19

0.76

1.1

0.98

1.06

u/l

1.21

167

Pre-eclampsia or eclampsia

621

1.19

0.76

1.0

1.1

0.99

1.05

u/l

1.08

251

Poor fetal growth

403

1.24

0.76

1.0

1.1

1.00

1.02

u/l

0.10

153

Superficial injury of hip and thigh

243

1.32

0.76

1.0

1.1

0.99

1.13

u/l

2.59

116

Benign neoplasm of major salivary glands

174

1.38

0.76

1.1

1.01

1.14

u/l

—

Cholelithiasis

232

1474

1.10

0.76

1.1

1.14

1.08

u/l

0.60

101

662

Peritonsillar abscess

539

1.21

0.76

1.1

1.04

1.06

u/l

0.10

234

Alzheimer’s disease (Atypical or mixed), excluding more controls

2.16

0.76

1.0

1.1

—

1.64

—

Effects of foreign body entering through natural orifice

558

1.20

0.75

1.0

1.1

1.03

1.05

u/l

0.17

257

Agranulocytosis

209

1.34

0.75

1.1

1.26

1.10

u/l

0.80

110

Insulin medication

155

1177

1.13

0.75

1.1

1.14

1.09

u/l

0.32

553

Emergency coronary revascularization (for ACS)

600

0.84

0.75

1.0

1.1

1.14

1.11

u/l

0.09

305

Cysts of oral region, not elsewhere classified

1.60

0.75

1.0

1.1

0.98

1.16

u/l

—

Cellulitis of external ear

2.10

0.74

1.0

0.94

1.16

u/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

158

1.39

0.74

1.1

1.01

1.16

u/l

—

Other female pelvic inflammatory diseases

378

1.25

0.74

1.1

0.99

1.08

u/l

0.74

170

Insulin, intermediate and long-acting

131

1132

1.14

0.73

1.1

1.10

1.08

u/l

0.10

532

Vulvovaginal ulceration/inflammation in other diseases

150

1.40

0.73

1.1

1.25

1.05

u/l

—

Nontoxic multinodular goitre

316

1.27

0.73

1.1

1.06

1.07

u/l

0.07

145

Striking against or struck by other objects

837

1.16

0.73

1.1

1.02

1.04

u/l

0.31

373

Hyperparathyroidism

251

1.30

0.73

1.0

1.31

1.10

u/l

0.44

126

Thrombocytopenia, unspecified

125

1.44

0.72

1.1

1.16

1.18

u/l

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

242

0.70

0.72

1.0

1.1

0.89

1.06

u/l

—

107

317

1.26

0.71

1.0

1.1

0.95

1.01

u/l

0.95

119

Superficial injury of wrist and hand

525

1.20

0.71

1.0

1.1

0.95

1.05

u/l

1.95

239

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

276

1495

1.09

0.71

1.1

1.25

1.04

u/l

1.12

145

650

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

218

0.69

0.71

1.0

1.1

1.28

1.06

u/l

—

Maternal care for other conditions predominantly related to pregnancy

682

1.17

0.71

1.1

1.05

1.02

u/l

0.22

251

L04AD Calcineurin inhibitors

229

1.31

0.71

1.0

1.1

1.14

1.08

u/l

0.31

115

Malignant neoplasm, wide definition for exclusion

276

1496

1.09

0.71

1.1

1.25

1.04

u/l

1.12

145

650

Alcohol-induced chronic pancreatitis

109

1.47

0.71

1.0

1.1

1.03

1.15

u/l

—

Other respiratory diseases principally affecting the interstitium

229

1.31

0.70

1.0

1.1

1.05

1.13

u/l

0.94

116

Other benign neoplasms of connective and other soft tissue

177

1.36

0.70

1.1

1.05

1.06

u/l

0.03

Otitis externa, unspecified

238

1.30

0.70

1.1

1.01

1.12

u/l

0.91

117

Malignant melanoma of skin

177

1.36

0.70

1.1

1.09

1.16

u/l

0.37

Insulin, fast-acting (human)

377

0.77

0.70

1.1

0.94

1.05

u/l

0.83

176

Other noninflammatory disorders of uterus, except cervix

289

0.78

0.70

1.0

1.1

1.37

1.07

u/l

0.58

128

Acute gastritis

126

1.43

0.70

1.1

0.95

1.15

u/l

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

160

1.38

0.70

1.0

1.1

1.15

1.05

u/l

—

Cyst of kidney

101

1.49

0.70

1.1

1.08

1.23

u/l

—

Retained placenta and membranes, without haemorrhage

309

0.74

0.70

1.0

1.1

1.01

1.06

u/l

—

137

Intestinal adhesions without obstruction

143

1.40

0.70

1.3

1.1

1.10

1.17

u/l

—

Thyrotoxicosis

527

1.20

0.69

1.1

1.11

1.08

u/l

0.16

247

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS